Basic Information

Terpenoid ID TKC205544
Cell line 0
Protein target 75
DiseaseNCIT 0
ORDO 0
ICD 424

Active subnetwork


Terpenoid-cell-disease Activity Association

ID Cell Line Synonyms Value Unit Type NCIt ORDO
TKC205544 HL-60 HL 60; HL.60 HL60; Human Leukemia-60 84000.0 nM IC50 C9154 Orphanet_519

Terpenoid-protein target Activity Association

ID Uniport Pref_name Gene name value unit type
TKC205544 Q9NUW8 Tyrosyl-DNA phosphodiesterase 1 TDP1 9441 nM Potency
TKC205544 Q99700 Ataxin-2 ATXN2 22387 nM Potency
TKC205544 P08183 ATP-dependent translocase ABCB1 ABCB1 429 nm/s Papp
TKC205544 Q13526 Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 PIN1 35481 nM Potency
TKC205544 O42275 Acetylcholinesterase ache 431000 nM IC50
TKC205544 P08173 Muscarinic acetylcholine receptor M4 CHRM4 4 % Inhibition
TKC205544 P08913 Alpha-2A adrenergic receptor ADRA2A 0 nM Ki
TKC205544 P08913 Alpha-2A adrenergic receptor ADRA2A 0 nM Ki
TKC205544 P08913 Alpha-2A adrenergic receptor ADRA2A 0.32 nM Ki
TKC205544 P08913 Alpha-2A adrenergic receptor ADRA2A 132 nM Ki
TKC205544 P08913 Alpha-2A adrenergic receptor ADRA2A 2.7 nM Ki
TKC205544 P08913 Alpha-2A adrenergic receptor ADRA2A 3.6 nM Ki
TKC205544 P08913 Alpha-2A adrenergic receptor ADRA2A 0.43 nM Ki
TKC205544 P08913 Alpha-2A adrenergic receptor ADRA2A 3.76 nM Ki
TKC205544 P08913 Alpha-2A adrenergic receptor ADRA2A 0.71 nM Ki
TKC205544 P08913 Alpha-2A adrenergic receptor ADRA2A 1.2 nM Ki
TKC205544 P08913 Alpha-2A adrenergic receptor ADRA2A 7.94 nM Ki
TKC205544 P08913 Alpha-2A adrenergic receptor ADRA2A 2.5 nM Ki
TKC205544 P08913 Alpha-2A adrenergic receptor ADRA2A 3.5 nM Ki
TKC205544 P08913 Alpha-2A adrenergic receptor ADRA2A 170 nM IC50
TKC205544 P08913 Alpha-2A adrenergic receptor ADRA2A 8 nM IC50
TKC205544 P08913 Alpha-2A adrenergic receptor ADRA2A 7.5 nM Ki
TKC205544 P08913 Alpha-2A adrenergic receptor ADRA2A 1.8 nM Ki
TKC205544 P08913 Alpha-2A adrenergic receptor ADRA2A 8.5 nM EC50
TKC205544 P08913 Alpha-2A adrenergic receptor ADRA2A 3.67 nM IC50
TKC205544 P0DMS8 Adenosine receptor A3 ADORA3 95 nM IC50
TKC205544 P10635 Cytochrome P450 2D6 CYP2D6 8 nM IC50
TKC205544 P10635 Cytochrome P450 2D6 CYP2D6 190 nM Ki
TKC205544 P14416 D(2) dopamine receptor DRD2 687 nM Ki
TKC205544 P14416 D(2) dopamine receptor DRD2 280 nM Ki
TKC205544 P14416 D(2) dopamine receptor DRD2 398.1 nM Ki
TKC205544 P15823 Alpha-1B adrenergic receptor Adra1b 7 nM Kd
TKC205544 P15823 Alpha-1B adrenergic receptor Adra1b 658 nM Ki
TKC205544 P15823 Alpha-1B adrenergic receptor Adra1b 517 nM Ki
TKC205544 P15823 Alpha-1B adrenergic receptor Adra1b 398 nM Ki
TKC205544 P15823 Alpha-1B adrenergic receptor Adra1b 360 nM Ki
TKC205544 P15823 Alpha-1B adrenergic receptor Adra1b 1000 nM IC50
TKC205544 P15823 Alpha-1B adrenergic receptor Adra1b 398 nM Ki
TKC205544 P15823 Alpha-1B adrenergic receptor Adra1b 398 nM Ki
TKC205544 P18089 Alpha-2B adrenergic receptor ADRA2B 1 nM Ki
TKC205544 P18089 Alpha-2B adrenergic receptor ADRA2B 1.18 nM Ki
TKC205544 P18089 Alpha-2B adrenergic receptor ADRA2B 77 nM Ki
TKC205544 P18089 Alpha-2B adrenergic receptor ADRA2B 4.59 nM Ki
TKC205544 P18089 Alpha-2B adrenergic receptor ADRA2B 1.2 nM Ki
TKC205544 P18089 Alpha-2B adrenergic receptor ADRA2B 1.99 nM Ki
TKC205544 P18089 Alpha-2B adrenergic receptor ADRA2B 2 nM Ki
TKC205544 P18089 Alpha-2B adrenergic receptor ADRA2B 4.6 nM Ki
TKC205544 P18089 Alpha-2B adrenergic receptor ADRA2B 15 nM Ki
TKC205544 P18089 Alpha-2B adrenergic receptor ADRA2B 1.2 nM Ki
TKC205544 P18825 Alpha-2C adrenergic receptor ADRA2C 1 nM Ki
TKC205544 P18825 Alpha-2C adrenergic receptor ADRA2C 0.13 nM Ki
TKC205544 P18825 Alpha-2C adrenergic receptor ADRA2C 0.78 nM Ki
TKC205544 P18825 Alpha-2C adrenergic receptor ADRA2C 0.55 nM Ki
TKC205544 P18825 Alpha-2C adrenergic receptor ADRA2C 0.25 nM Ki
TKC205544 P18825 Alpha-2C adrenergic receptor ADRA2C 0.5 nM Ki
TKC205544 P18825 Alpha-2C adrenergic receptor ADRA2C 2.3 nM Ki
TKC205544 P18825 Alpha-2C adrenergic receptor ADRA2C 1.9 nM Ki
TKC205544 P18825 Alpha-2C adrenergic receptor ADRA2C 0.8 nM Ki
TKC205544 P18825 Alpha-2C adrenergic receptor ADRA2C 27.1 nM IC50
TKC205544 P19327 5-hydroxytryptamine receptor 1A Htr1a 72 nM Ki
TKC205544 P19327 5-hydroxytryptamine receptor 1A Htr1a 1318.26 nM Ki
TKC205544 P19327 5-hydroxytryptamine receptor 1A Htr1a 125.89 nM Ki
TKC205544 P21554 Cannabinoid receptor 1 CNR1 35 % Inhibition
TKC205544 P21728 D(1A) dopamine receptor DRD1 2909 nM Potency
TKC205544 P21728 D(1A) dopamine receptor DRD1 >10000 nM Ki
TKC205544 P23975 Sodium-dependent noradrenaline transporter SLC6A2 >20000 nM IC50
TKC205544 P25100 Alpha-1D adrenergic receptor ADRA1D 2 nM Ki
TKC205544 P25100 Alpha-1D adrenergic receptor ADRA1D 158.48 nM Ki
TKC205544 P25100 Alpha-1D adrenergic receptor ADRA1D 954.99 nM Ki
TKC205544 P25100 Alpha-1D adrenergic receptor ADRA1D 289 nM Ki
TKC205544 P28223 5-hydroxytryptamine receptor 2A HTR2A >10000 nM Ki
TKC205544 P28223 5-hydroxytryptamine receptor 2A HTR2A 252 nM Ki
TKC205544 P28223 5-hydroxytryptamine receptor 2A HTR2A 288.4 nM Ki
TKC205544 P28223 5-hydroxytryptamine receptor 2A HTR2A 1000 nM Ki
TKC205544 P28335 5-hydroxytryptamine receptor 2C HTR2C >10000 nM Ki
TKC205544 P28335 5-hydroxytryptamine receptor 2C HTR2C 1690 nM Ki
TKC205544 P28335 5-hydroxytryptamine receptor 2C HTR2C 645.65 nM Ki
TKC205544 P28335 5-hydroxytryptamine receptor 2C HTR2C 1000 nM Ki
TKC205544 P28564 5-hydroxytryptamine receptor 1B Htr1b 8700 nM Ki
TKC205544 P28564 5-hydroxytryptamine receptor 1B Htr1b 6309.57 nM Ki
TKC205544 P28564 5-hydroxytryptamine receptor 1B Htr1b 19 nM Ki
TKC205544 P31645 Sodium-dependent serotonin transporter SLC6A4 1000 nM Ki
TKC205544 P35367 Histamine H1 receptor HRH1 30 % Inhibition
TKC205544 P35462 D(3) dopamine receptor DRD3 2489 nM Ki
TKC205544 P35462 D(3) dopamine receptor DRD3 3981.07 nM Ki
TKC205544 P41595 5-hydroxytryptamine receptor 2B HTR2B 47 nM Ki
TKC205544 P41595 5-hydroxytryptamine receptor 2B HTR2B 398.1 nM Ki
TKC205544 P41595 5-hydroxytryptamine receptor 2B HTR2B 40.6 nM Ki
TKC205544 P41595 5-hydroxytryptamine receptor 2B HTR2B 15.1 nM Ki
TKC205544 P41595 5-hydroxytryptamine receptor 2B HTR2B 28.84 nM Ki
TKC205544 P41595 5-hydroxytryptamine receptor 2B HTR2B 14.3 nM Ki
TKC205544 P41595 5-hydroxytryptamine receptor 2B HTR2B 31.62 nM Ki
TKC205544 P41595 5-hydroxytryptamine receptor 2B HTR2B 398.11 nM Ki
TKC205544 P43140 Alpha-1A adrenergic receptor Adra1a 500 nM Ki
TKC205544 P43140 Alpha-1A adrenergic receptor Adra1a 150 nM Ki
TKC205544 P43140 Alpha-1A adrenergic receptor Adra1a 562 nM Ki
TKC205544 P43140 Alpha-1A adrenergic receptor Adra1a 64 nM Ki
TKC205544 P43140 Alpha-1A adrenergic receptor Adra1a 236 nM Ki
TKC205544 P43140 Alpha-1A adrenergic receptor Adra1a 1100 nM Ki
TKC205544 P43140 Alpha-1A adrenergic receptor Adra1a 251.18 nM Ki
TKC205544 P43140 Alpha-1A adrenergic receptor Adra1a 59 nM Ki
TKC205544 P50406 5-hydroxytryptamine receptor 6 HTR6 784 nM Ki
TKC205544 Q96KQ7 Histone-lysine N-methyltransferase EHMT2 EHMT2 21192 nM Potency
TKC205544 Q6W5P4 Neuropeptide S receptor NPSR1 -3 % Inhibition
TKC205544 Q92830 Histone acetyltransferase KAT2A KAT2A 31623 nM Potency
TKC205544 P49798 Regulator of G-protein signaling 4 RGS4 2117 nM Potency
TKC205544 P11387 DNA topoisomerase 1 TOP1 30000 nM IC50
TKC205544 P22002 Voltage-dependent L-type calcium channel subunit alpha-1C Cacna1c 45 nM Ki
TKC205544 P22002 Voltage-dependent L-type calcium channel subunit alpha-1C Cacna1c 1000 nM Ki
TKC205544 P30304 M-phase inducer phosphatase 1 CDC25A 22300 nM IC50
TKC205544 P42345 Serine/threonine-protein kinase mTOR MTOR 14689 nM Potency
TKC205544 P35348 Alpha-1A adrenergic receptor ADRA1A 398 nM Kd
TKC205544 P35348 Alpha-1A adrenergic receptor ADRA1A 148 nM Kd
TKC205544 P35348 Alpha-1A adrenergic receptor ADRA1A 770 nM Ki
TKC205544 P35348 Alpha-1A adrenergic receptor ADRA1A 199.52 nM Ki
TKC205544 P35348 Alpha-1A adrenergic receptor ADRA1A 3162.28 nM Ki
TKC205544 P35348 Alpha-1A adrenergic receptor ADRA1A 1057 nM Ki
TKC205544 P35368 Alpha-1B adrenergic receptor ADRA1B 1 nM Ki
TKC205544 P35368 Alpha-1B adrenergic receptor ADRA1B 158.48 nM Ki
TKC205544 P35368 Alpha-1B adrenergic receptor ADRA1B 2398.83 nM Ki
TKC205544 P35368 Alpha-1B adrenergic receptor ADRA1B 966 nM Ki
TKC205544 O95342 Bile salt export pump ABCB11 254000 nM IC50
TKC205544 Q14974 Importin subunit beta-1 KPNB1 112202 nM Potency
TKC205544 P15289 Arylsulfatase A ARSA 2393 nM Potency
TKC205544 P80244 ATP-dependent Clp protease proteolytic subunit clpP 14125 nM Potency
TKC205544 P08908 5-hydroxytryptamine receptor 1A HTR1A 4500 nM Ki
TKC205544 P08908 5-hydroxytryptamine receptor 1A HTR1A 1500 nM Ki
TKC205544 P08908 5-hydroxytryptamine receptor 1A HTR1A 642 nM Ki
TKC205544 P08908 5-hydroxytryptamine receptor 1A HTR1A 1258.92 nM Ki
TKC205544 P34972 Cannabinoid receptor 2 CNR2 20 % Inhibition
TKC205544 Q9R0C9 Sigma non-opioid intracellular receptor 1 Sigmar1 >10000 nM Ki
TKC205544 P35498 Sodium channel protein type 1 subunit alpha SCN1A 33000 nM IC50
TKC205544 P61169 D(2) dopamine receptor Drd2 1125 nM IC50
TKC205544 P61169 D(2) dopamine receptor Drd2 158 nM Ki
TKC205544 P61169 D(2) dopamine receptor Drd2 926 nM Ki
TKC205544 P61169 D(2) dopamine receptor Drd2 501.18 nM Ki
TKC205544 P61169 D(2) dopamine receptor Drd2 2000 nM Ki
TKC205544 P52292 Importin subunit alpha-1 KPNA2 >500000 nM EC50
TKC205544 O77830 Alpha-2B adrenergic receptor ADRA2B 21 nM Ki
TKC205544 O77830 Alpha-2B adrenergic receptor ADRA2B 13.5 nM Ki
TKC205544 P19328 Alpha-2B adrenergic receptor Adra2b 2 nM Ki
TKC205544 P19328 Alpha-2B adrenergic receptor Adra2b 0.45 nM Ki
TKC205544 P19328 Alpha-2B adrenergic receptor Adra2b 100 nM Ki
TKC205544 P19328 Alpha-2B adrenergic receptor Adra2b 16.8 nM Ki
TKC205544 P34969 5-hydroxytryptamine receptor 7 HTR7 2850 nM Ki
TKC205544 P18130 Alpha-1A adrenergic receptor ADRA1A 4 nM Ki
TKC205544 P18130 Alpha-1A adrenergic receptor ADRA1A 142 nM Ki
TKC205544 P18130 Alpha-1A adrenergic receptor ADRA1A 220 nM Ki
TKC205544 P18130 Alpha-1A adrenergic receptor ADRA1A 200 nM Ki
TKC205544 P18130 Alpha-1A adrenergic receptor ADRA1A 220 nM Ki
TKC205544 P22086 Alpha-2C adrenergic receptor Adra2c 1 nM Ki
TKC205544 P22086 Alpha-2C adrenergic receptor Adra2c 17 nM Ki
TKC205544 P22086 Alpha-2C adrenergic receptor Adra2c 10 nM Ki
TKC205544 P22086 Alpha-2C adrenergic receptor Adra2c 7857 nM Ki
TKC205544 P22086 Alpha-2C adrenergic receptor Adra2c 320 nM Ki
TKC205544 P22086 Alpha-2C adrenergic receptor Adra2c 0.44 nM Ki
TKC205544 P22086 Alpha-2C adrenergic receptor Adra2c 31.62 nM Ki
TKC205544 P22086 Alpha-2C adrenergic receptor Adra2c 10.6 nM Ki
TKC205544 P23944 Alpha-1D adrenergic receptor Adra1d 52 nM Ki
TKC205544 P30545 Alpha-2B adrenergic receptor Adra2b 1 nM Ki
TKC205544 P30545 Alpha-2B adrenergic receptor Adra2b 61.66 nM Ki
TKC205544 Q28838 Alpha-2A adrenergic receptor ADRA2A 49 nM Ki
TKC205544 Q28838 Alpha-2A adrenergic receptor ADRA2A 79 nM Ki
TKC205544 O02824 Alpha-1A adrenergic receptor ADRA1A 1100 nM Ki
TKC205544 O77621 Alpha-1A adrenergic receptor ADRA1A 32 nM Ki
TKC205544 P14842 5-hydroxytryptamine receptor 2A Htr2a 1622 nM Ki
TKC205544 P14842 5-hydroxytryptamine receptor 2A Htr2a >10000 nM Ki
TKC205544 P14842 5-hydroxytryptamine receptor 2A Htr2a >10000 nM Ki
TKC205544 P14842 5-hydroxytryptamine receptor 2A Htr2a 2258 nM Ki
TKC205544 P14842 5-hydroxytryptamine receptor 2A Htr2a 1000 nM Ki
TKC205544 P43119 Prostacyclin receptor PTGIR 8 % Inhibition
TKC205544 G5EF15 Cytoplasmic zinc-finger protein pos-1 >300000 nM EC50
TKC205544 O43614 Orexin receptor type 2 HCRTR2 9 % Inhibition
TKC205544 P18871 Alpha-2A adrenergic receptor ADRA2A 4 nM Ki
TKC205544 P18871 Alpha-2A adrenergic receptor ADRA2A >10000 nM Ki
TKC205544 P19020 D(3) dopamine receptor Drd3 2430 nM Ki
TKC205544 P21462 fMet-Leu-Phe receptor FPR1 -6 % Inhibition
TKC205544 P25115 D(1B) dopamine receptor Drd5 2000 nM Ki
TKC205544 P30994 5-hydroxytryptamine receptor 2B Htr2b 50.11 nM Ki
TKC205544 P30994 5-hydroxytryptamine receptor 2B Htr2b 58.88 nM Ki
TKC205544 P30994 5-hydroxytryptamine receptor 2B Htr2b 53.1 nM Ki
TKC205544 P30994 5-hydroxytryptamine receptor 2B Htr2b 35.8 nM Ki
TKC205544 P30994 5-hydroxytryptamine receptor 2B Htr2b 39.81 nM Ki
TKC205544 P34968 5-hydroxytryptamine receptor 2C Htr2c >10000 nM Ki
TKC205544 P49683 Prolactin-releasing peptide receptor PRLHR 1 % Inhibition
TKC205544 P51685 C-C chemokine receptor type 8 CCR8 5 % Inhibition
TKC205544 P61073 C-X-C chemokine receptor type 4 CXCR4 21 % Inhibition
TKC205544 Q8TDV5 Glucose-dependent insulinotropic receptor GPR119 8 % Inhibition
TKC205544 Q9XUB2 Zinc finger protein mex-5 mex-5 103486 nM EC50
TKC205544 O08892 5-hydroxytryptamine receptor 1B HTR1B 50.11 nM Ki
TKC205544 O77715 Alpha-2B adrenergic receptor ADRA2B 28 nM Ki
TKC205544 O77715 Alpha-2B adrenergic receptor ADRA2B 0.11 nM Ki
TKC205544 P08909 5-hydroxytryptamine receptor 2C Htr2c >10000 nM Ki
TKC205544 P08909 5-hydroxytryptamine receptor 2C Htr2c 5011.87 nM Ki
TKC205544 P08909 5-hydroxytryptamine receptor 2C Htr2c >10000 nM Ki
TKC205544 P08909 5-hydroxytryptamine receptor 2C Htr2c >10000 nM Ki
TKC205544 P11614 5-hydroxytryptamine receptor 1D HTR1D 5.24 nM Ki
TKC205544 P18841 Alpha-1B adrenergic receptor ADRA1B 670 nM Ki
TKC205544 P23977 Sodium-dependent dopamine transporter Slc6a3 1000 nM Ki
TKC205544 P23979 5-hydroxytryptamine receptor 3A Htr3a >10000 nM Ki
TKC205544 P23979 5-hydroxytryptamine receptor 3A Htr3a 1000 nM Ki
TKC205544 P28221 5-hydroxytryptamine receptor 1D HTR1D 40 nM Ki
TKC205544 P28221 5-hydroxytryptamine receptor 1D HTR1D 59 nM Ki
TKC205544 P28221 5-hydroxytryptamine receptor 1D HTR1D 15.84 nM Ki
TKC205544 P28221 5-hydroxytryptamine receptor 1D HTR1D 19.95 nM Ki
TKC205544 P28222 5-hydroxytryptamine receptor 1B HTR1B 5 nM Ki
TKC205544 P28222 5-hydroxytryptamine receptor 1B HTR1B 16 nM Ki
TKC205544 P28222 5-hydroxytryptamine receptor 1B HTR1B 39.81 nM Ki
TKC205544 P28222 5-hydroxytryptamine receptor 1B HTR1B 158.48 nM Ki
TKC205544 P28334 5-hydroxytryptamine receptor 1B Htr1b >10000 nM Ki
TKC205544 P28565 5-hydroxytryptamine receptor 1D Htr1d 30.9 nM Ki
TKC205544 P28566 5-hydroxytryptamine receptor 1E HTR1E 3434 nM Ki
TKC205544 P28566 5-hydroxytryptamine receptor 1E HTR1E 1258.92 nM Ki
TKC205544 P30939 5-hydroxytryptamine receptor 1F HTR1F 91.2 nM Ki
TKC205544 P30939 5-hydroxytryptamine receptor 1F HTR1F 92 nM Ki
TKC205544 P30940 5-hydroxytryptamine receptor 1F Htr1f 562.34 nM Ki
TKC205544 P30966 5-hydroxytryptamine receptor 5A Htr5a 1000 nM Ki
TKC205544 P30966 5-hydroxytryptamine receptor 5A Htr5a 1000 nM Ki
TKC205544 P30966 5-hydroxytryptamine receptor 5A Htr5a 1000 nM Ki
TKC205544 P30966 5-hydroxytryptamine receptor 5A Htr5a >10000 nM Ki
TKC205544 P31387 5-hydroxytryptamine receptor 5B Htr5b 1000 nM Ki
TKC205544 P31387 5-hydroxytryptamine receptor 5B Htr5b 1000 nM Ki
TKC205544 P32305 5-hydroxytryptamine receptor 7 Htr7 1000 nM Ki
TKC205544 P35364 5-hydroxytryptamine receptor 5A Htr5a 1000 nM Ki
TKC205544 P35364 5-hydroxytryptamine receptor 5A Htr5a 1000 nM Ki
TKC205544 P35365 5-hydroxytryptamine receptor 5B Htr5b 1000 nM Ki
TKC205544 P35365 5-hydroxytryptamine receptor 5B Htr5b 1000 nM Ki
TKC205544 P35365 5-hydroxytryptamine receptor 5B Htr5b 1000 nM Ki
TKC205544 P35405 Alpha-2C adrenergic receptor ADRA2C 20 nM Ki
TKC205544 Q02284 5-hydroxytryptamine receptor 1F Htr1f 63.09 nM Ki
TKC205544 Q4G017 Nischarin Nisch >10000 nM Ki
TKC205544 P22909 Alpha-2A adrenergic receptor Adra2a 63.09 nM Ki

Protein target-disease Activity Association

Uniport ID Uniport Name ICD-11
P08183 MDR1_HUMAN Lung cancer [ICD-11: 2C25]
P08183 MDR1_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P08183 MDR1_HUMAN Bacterial infection [ICD-11: 1A00-1C4Z]
P08183 MDR1_HUMAN Acute myeloid leukaemia [ICD-11: 2A60]
P08183 MDR1_HUMAN Adrenal cancer [ICD-11: 2D11]
P08183 MDR1_HUMAN Ovarian cancer [ICD-11: 2C73]
Q13526 PIN1_HUMAN Lung cancer [ICD-11: 2C25]
Q13526 PIN1_HUMAN Nasopharyngeal cancer [ICD-11: 2B6B]
P08173 ACM4_HUMAN Asthma [ICD-11: CA23]
P08173 ACM4_HUMAN Eye anterior segment structural developmental anomaly [ICD-11: LA11]
P08173 ACM4_HUMAN Glaucoma [ICD-11: 9C61]
P08173 ACM4_HUMAN Nausea/vomiting [ICD-11: MD90]
P08173 ACM4_HUMAN Respiratory system disease [ICD-11: CB40-CB7Z]
P08173 ACM4_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P08913 ADA2A_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P08913 ADA2A_HUMAN Opioid use disorder [ICD-11: 6C43]
P08913 ADA2A_HUMAN Substance abuse [ICD-11: 6C40]
P08913 ADA2A_HUMAN Pain [ICD-11: MG30-MG3Z]
P08913 ADA2A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P08913 ADA2A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P08913 ADA2A_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P08913 ADA2A_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P08913 ADA2A_HUMAN Obesity [ICD-11: 5B80-5B81]
P08913 ADA2A_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P08913 ADA2A_HUMAN Opioid use disorder [ICD-11: 6C43]
P08913 ADA2A_HUMAN Substance abuse [ICD-11: 6C40]
P08913 ADA2A_HUMAN Pain [ICD-11: MG30-MG3Z]
P08913 ADA2A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P08913 ADA2A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P08913 ADA2A_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P08913 ADA2A_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P08913 ADA2A_HUMAN Obesity [ICD-11: 5B80-5B81]
P08913 ADA2A_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P08913 ADA2A_HUMAN Opioid use disorder [ICD-11: 6C43]
P08913 ADA2A_HUMAN Substance abuse [ICD-11: 6C40]
P08913 ADA2A_HUMAN Pain [ICD-11: MG30-MG3Z]
P08913 ADA2A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P08913 ADA2A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P08913 ADA2A_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P08913 ADA2A_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P08913 ADA2A_HUMAN Obesity [ICD-11: 5B80-5B81]
P08913 ADA2A_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P08913 ADA2A_HUMAN Opioid use disorder [ICD-11: 6C43]
P08913 ADA2A_HUMAN Substance abuse [ICD-11: 6C40]
P08913 ADA2A_HUMAN Pain [ICD-11: MG30-MG3Z]
P08913 ADA2A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P08913 ADA2A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P08913 ADA2A_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P08913 ADA2A_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P08913 ADA2A_HUMAN Obesity [ICD-11: 5B80-5B81]
P08913 ADA2A_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P08913 ADA2A_HUMAN Opioid use disorder [ICD-11: 6C43]
P08913 ADA2A_HUMAN Substance abuse [ICD-11: 6C40]
P08913 ADA2A_HUMAN Pain [ICD-11: MG30-MG3Z]
P08913 ADA2A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P08913 ADA2A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P08913 ADA2A_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P08913 ADA2A_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P08913 ADA2A_HUMAN Obesity [ICD-11: 5B80-5B81]
P08913 ADA2A_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P08913 ADA2A_HUMAN Opioid use disorder [ICD-11: 6C43]
P08913 ADA2A_HUMAN Substance abuse [ICD-11: 6C40]
P08913 ADA2A_HUMAN Pain [ICD-11: MG30-MG3Z]
P08913 ADA2A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P08913 ADA2A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P08913 ADA2A_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P08913 ADA2A_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P08913 ADA2A_HUMAN Obesity [ICD-11: 5B80-5B81]
P08913 ADA2A_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P08913 ADA2A_HUMAN Opioid use disorder [ICD-11: 6C43]
P08913 ADA2A_HUMAN Substance abuse [ICD-11: 6C40]
P08913 ADA2A_HUMAN Pain [ICD-11: MG30-MG3Z]
P08913 ADA2A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P08913 ADA2A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P08913 ADA2A_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P08913 ADA2A_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P08913 ADA2A_HUMAN Obesity [ICD-11: 5B80-5B81]
P08913 ADA2A_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P08913 ADA2A_HUMAN Opioid use disorder [ICD-11: 6C43]
P08913 ADA2A_HUMAN Substance abuse [ICD-11: 6C40]
P08913 ADA2A_HUMAN Pain [ICD-11: MG30-MG3Z]
P08913 ADA2A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P08913 ADA2A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P08913 ADA2A_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P08913 ADA2A_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P08913 ADA2A_HUMAN Obesity [ICD-11: 5B80-5B81]
P08913 ADA2A_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P08913 ADA2A_HUMAN Opioid use disorder [ICD-11: 6C43]
P08913 ADA2A_HUMAN Substance abuse [ICD-11: 6C40]
P08913 ADA2A_HUMAN Pain [ICD-11: MG30-MG3Z]
P08913 ADA2A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P08913 ADA2A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P08913 ADA2A_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P08913 ADA2A_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P08913 ADA2A_HUMAN Obesity [ICD-11: 5B80-5B81]
P08913 ADA2A_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P08913 ADA2A_HUMAN Opioid use disorder [ICD-11: 6C43]
P08913 ADA2A_HUMAN Substance abuse [ICD-11: 6C40]
P08913 ADA2A_HUMAN Pain [ICD-11: MG30-MG3Z]
P08913 ADA2A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P08913 ADA2A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P08913 ADA2A_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P08913 ADA2A_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P08913 ADA2A_HUMAN Obesity [ICD-11: 5B80-5B81]
P08913 ADA2A_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P08913 ADA2A_HUMAN Opioid use disorder [ICD-11: 6C43]
P08913 ADA2A_HUMAN Substance abuse [ICD-11: 6C40]
P08913 ADA2A_HUMAN Pain [ICD-11: MG30-MG3Z]
P08913 ADA2A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P08913 ADA2A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P08913 ADA2A_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P08913 ADA2A_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P08913 ADA2A_HUMAN Obesity [ICD-11: 5B80-5B81]
P08913 ADA2A_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P08913 ADA2A_HUMAN Opioid use disorder [ICD-11: 6C43]
P08913 ADA2A_HUMAN Substance abuse [ICD-11: 6C40]
P08913 ADA2A_HUMAN Pain [ICD-11: MG30-MG3Z]
P08913 ADA2A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P08913 ADA2A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P08913 ADA2A_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P08913 ADA2A_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P08913 ADA2A_HUMAN Obesity [ICD-11: 5B80-5B81]
P08913 ADA2A_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P08913 ADA2A_HUMAN Opioid use disorder [ICD-11: 6C43]
P08913 ADA2A_HUMAN Substance abuse [ICD-11: 6C40]
P08913 ADA2A_HUMAN Pain [ICD-11: MG30-MG3Z]
P08913 ADA2A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P08913 ADA2A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P08913 ADA2A_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P08913 ADA2A_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P08913 ADA2A_HUMAN Obesity [ICD-11: 5B80-5B81]
P08913 ADA2A_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P08913 ADA2A_HUMAN Opioid use disorder [ICD-11: 6C43]
P08913 ADA2A_HUMAN Substance abuse [ICD-11: 6C40]
P08913 ADA2A_HUMAN Pain [ICD-11: MG30-MG3Z]
P08913 ADA2A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P08913 ADA2A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P08913 ADA2A_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P08913 ADA2A_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P08913 ADA2A_HUMAN Obesity [ICD-11: 5B80-5B81]
P08913 ADA2A_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P08913 ADA2A_HUMAN Opioid use disorder [ICD-11: 6C43]
P08913 ADA2A_HUMAN Substance abuse [ICD-11: 6C40]
P08913 ADA2A_HUMAN Pain [ICD-11: MG30-MG3Z]
P08913 ADA2A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P08913 ADA2A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P08913 ADA2A_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P08913 ADA2A_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P08913 ADA2A_HUMAN Obesity [ICD-11: 5B80-5B81]
P08913 ADA2A_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P08913 ADA2A_HUMAN Opioid use disorder [ICD-11: 6C43]
P08913 ADA2A_HUMAN Substance abuse [ICD-11: 6C40]
P08913 ADA2A_HUMAN Pain [ICD-11: MG30-MG3Z]
P08913 ADA2A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P08913 ADA2A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P08913 ADA2A_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P08913 ADA2A_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P08913 ADA2A_HUMAN Obesity [ICD-11: 5B80-5B81]
P08913 ADA2A_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P08913 ADA2A_HUMAN Opioid use disorder [ICD-11: 6C43]
P08913 ADA2A_HUMAN Substance abuse [ICD-11: 6C40]
P08913 ADA2A_HUMAN Pain [ICD-11: MG30-MG3Z]
P08913 ADA2A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P08913 ADA2A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P08913 ADA2A_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P08913 ADA2A_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P08913 ADA2A_HUMAN Obesity [ICD-11: 5B80-5B81]
P08913 ADA2A_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P08913 ADA2A_HUMAN Opioid use disorder [ICD-11: 6C43]
P08913 ADA2A_HUMAN Substance abuse [ICD-11: 6C40]
P08913 ADA2A_HUMAN Pain [ICD-11: MG30-MG3Z]
P08913 ADA2A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P08913 ADA2A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P08913 ADA2A_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P08913 ADA2A_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P08913 ADA2A_HUMAN Obesity [ICD-11: 5B80-5B81]
P08913 ADA2A_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P08913 ADA2A_HUMAN Opioid use disorder [ICD-11: 6C43]
P08913 ADA2A_HUMAN Substance abuse [ICD-11: 6C40]
P08913 ADA2A_HUMAN Pain [ICD-11: MG30-MG3Z]
P08913 ADA2A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P08913 ADA2A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P08913 ADA2A_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P08913 ADA2A_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P08913 ADA2A_HUMAN Obesity [ICD-11: 5B80-5B81]
P0DMS8 AA3R_HUMAN Psoriasis [ICD-11: EA90]
P0DMS8 AA3R_HUMAN Rheumatoid arthritis [ICD-11: FA20]
P0DMS8 AA3R_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P0DMS8 AA3R_HUMAN Heart failure [ICD-11: BD10-BD1Z]
P0DMS8 AA3R_HUMAN Hepatitis virus infection [ICD-11: 1E50-1E51]
P0DMS8 AA3R_HUMAN Liver cancer [ICD-11: 2C12]
P0DMS8 AA3R_HUMAN Malaria [ICD-11: 1F40-1F45]
P0DMS8 AA3R_HUMAN Ischaemic heart disease [ICD-11: BA6Z]
P0DMS8 AA3R_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
P0DMS8 AA3R_HUMAN Cerebral ischaemia [ICD-11: 8B1Z]
P0DMS8 AA3R_HUMAN Multiple sclerosis [ICD-11: 8A40]
P0DMS8 AA3R_HUMAN Glaucoma [ICD-11: 9C61]
P0DMS8 AA3R_HUMAN Ischemia [ICD-11: 8B10-8B11]
P10635 CP2D6_HUMAN Insomnia [ICD-11: 7A00-7A0Z]
P10635 CP2D6_HUMAN Malaria [ICD-11: 1F40-1F45]
P10635 CP2D6_HUMAN Migraine [ICD-11: 8A80]
P10635 CP2D6_HUMAN Insomnia [ICD-11: 7A00-7A0Z]
P10635 CP2D6_HUMAN Malaria [ICD-11: 1F40-1F45]
P10635 CP2D6_HUMAN Migraine [ICD-11: 8A80]
P14416 DRD2_HUMAN Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z]
P14416 DRD2_HUMAN Alzheimer disease [ICD-11: 8A20]
P14416 DRD2_HUMAN Asthma [ICD-11: CA23]
P14416 DRD2_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P14416 DRD2_HUMAN Bipolar disorder [ICD-11: 6A60]
P14416 DRD2_HUMAN Breathing abnormality [ICD-11: MD11]
P14416 DRD2_HUMAN Cardiovascular disease [ICD-11: BA00-BE2Z]
P14416 DRD2_HUMAN Cerebral ischaemia [ICD-11: 8B1Z]
P14416 DRD2_HUMAN Depression [ICD-11: 6A70-6A7Z]
P14416 DRD2_HUMAN Digestive system disease [ICD-11: DE2Z]
P14416 DRD2_HUMAN Essential hypertension [ICD-11: BA00]
P14416 DRD2_HUMAN Faecal incontinence [ICD-11: ME07]
P14416 DRD2_HUMAN Fibrosis [ICD-11: GA14-GC01]
P14416 DRD2_HUMAN Gangrene [ICD-11: MC85]
P14416 DRD2_HUMAN General pain disorder [ICD-11: 8E43]
P14416 DRD2_HUMAN Glaucoma [ICD-11: 9C61]
P14416 DRD2_HUMAN Heart failure [ICD-11: BD10-BD1Z]
P14416 DRD2_HUMAN Hyperaemia [ICD-11: 9A61-9B7Y]
P14416 DRD2_HUMAN Hypertension [ICD-11: BA00-BA04]
P14416 DRD2_HUMAN Hypotension [ICD-11: BA20-BA21]
P14416 DRD2_HUMAN Inborn porphyrin/heme metabolism error [ICD-11: 5C58]
P14416 DRD2_HUMAN Insomnia [ICD-11: 7A00-7A0Z]
P14416 DRD2_HUMAN Itching [ICD-11: 1F28-1G07]
P14416 DRD2_HUMAN Migraine [ICD-11: 8A80]
P14416 DRD2_HUMAN Nausea/vomiting [ICD-11: MD90]
P14416 DRD2_HUMAN Pain [ICD-11: MG30-MG3Z]
P14416 DRD2_HUMAN Parkinsonism [ICD-11: 8A00]
P14416 DRD2_HUMAN Pituitary gland disorder [ICD-11: 5A60-5A61]
P14416 DRD2_HUMAN Postpartum haemorrhage [ICD-11: JA43]
P14416 DRD2_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P14416 DRD2_HUMAN Pulmonary hypertension [ICD-11: BB01]
P14416 DRD2_HUMAN Schizophrenia [ICD-11: 6A20]
P14416 DRD2_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P14416 DRD2_HUMAN Substance abuse [ICD-11: 6C40]
P14416 DRD2_HUMAN Thyrotoxicosis [ICD-11: 5A02]
P14416 DRD2_HUMAN Type 2 diabetes mellitus [ICD-11: 5A11]
P14416 DRD2_HUMAN Choreiform disorder [ICD-11: 8A01]
P14416 DRD2_HUMAN Lung cancer [ICD-11: 2C25]
P14416 DRD2_HUMAN Restless legs syndrome [ICD-11: 7A80]
P14416 DRD2_HUMAN Intellectual development disorder [ICD-11: LD90]
P14416 DRD2_HUMAN Brain cancer [ICD-11: 2A00]
P14416 DRD2_HUMAN Carcinoid syndrome [ICD-11: 5B10]
P14416 DRD2_HUMAN Chronic kidney disease [ICD-11: GB61]
P14416 DRD2_HUMAN Endocrine gland neoplasm [ICD-11: 2F37]
P14416 DRD2_HUMAN Endometrial cancer [ICD-11: 2C76]
P14416 DRD2_HUMAN Gastroduodenal motor/secretory disorder [ICD-11: DA41]
P14416 DRD2_HUMAN Idiopathic interstitial pneumonitis [ICD-11: CB03]
P14416 DRD2_HUMAN Leukaemia [ICD-11: 2A60-2B33]
P14416 DRD2_HUMAN Lymphoma [ICD-11: 2A80-2A86]
P14416 DRD2_HUMAN Multiple myeloma [ICD-11: 2A83]
P14416 DRD2_HUMAN Pancreatic cancer [ICD-11: 2C10]
P14416 DRD2_HUMAN Psoriasis [ICD-11: EA90]
P14416 DRD2_HUMAN Respiratory infection [ICD-11: CA07-CA4Z]
P14416 DRD2_HUMAN Schizoaffective disorder [ICD-11: 6A21]
P14416 DRD2_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P14416 DRD2_HUMAN Stomach cancer [ICD-11: 2B72]
P14416 DRD2_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
P14416 DRD2_HUMAN Tonus and reflex abnormality [ICD-11: MB47]
P14416 DRD2_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P14416 DRD2_HUMAN Fatigue [ICD-11: MG22]
P14416 DRD2_HUMAN Bacterial infection [ICD-11: 1A00-1C4Z]
P14416 DRD2_HUMAN Chronic obstructive pulmonary disease [ICD-11: CA22]
P14416 DRD2_HUMAN Indeterminate colitis [ICD-11: DD72]
P14416 DRD2_HUMAN Nicotine use disorder [ICD-11: 6C4A]
P14416 DRD2_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
P14416 DRD2_HUMAN Unspecific substance use disorder [ICD-11: 6C4Z]
P14416 DRD2_HUMAN Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z]
P14416 DRD2_HUMAN Thrombocytopenia [ICD-11: 3B64]
P14416 DRD2_HUMAN Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z]
P14416 DRD2_HUMAN Alzheimer disease [ICD-11: 8A20]
P14416 DRD2_HUMAN Asthma [ICD-11: CA23]
P14416 DRD2_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P14416 DRD2_HUMAN Bipolar disorder [ICD-11: 6A60]
P14416 DRD2_HUMAN Breathing abnormality [ICD-11: MD11]
P14416 DRD2_HUMAN Cardiovascular disease [ICD-11: BA00-BE2Z]
P14416 DRD2_HUMAN Cerebral ischaemia [ICD-11: 8B1Z]
P14416 DRD2_HUMAN Depression [ICD-11: 6A70-6A7Z]
P14416 DRD2_HUMAN Digestive system disease [ICD-11: DE2Z]
P14416 DRD2_HUMAN Essential hypertension [ICD-11: BA00]
P14416 DRD2_HUMAN Faecal incontinence [ICD-11: ME07]
P14416 DRD2_HUMAN Fibrosis [ICD-11: GA14-GC01]
P14416 DRD2_HUMAN Gangrene [ICD-11: MC85]
P14416 DRD2_HUMAN General pain disorder [ICD-11: 8E43]
P14416 DRD2_HUMAN Glaucoma [ICD-11: 9C61]
P14416 DRD2_HUMAN Heart failure [ICD-11: BD10-BD1Z]
P14416 DRD2_HUMAN Hyperaemia [ICD-11: 9A61-9B7Y]
P14416 DRD2_HUMAN Hypertension [ICD-11: BA00-BA04]
P14416 DRD2_HUMAN Hypotension [ICD-11: BA20-BA21]
P14416 DRD2_HUMAN Inborn porphyrin/heme metabolism error [ICD-11: 5C58]
P14416 DRD2_HUMAN Insomnia [ICD-11: 7A00-7A0Z]
P14416 DRD2_HUMAN Itching [ICD-11: 1F28-1G07]
P14416 DRD2_HUMAN Migraine [ICD-11: 8A80]
P14416 DRD2_HUMAN Nausea/vomiting [ICD-11: MD90]
P14416 DRD2_HUMAN Pain [ICD-11: MG30-MG3Z]
P14416 DRD2_HUMAN Parkinsonism [ICD-11: 8A00]
P14416 DRD2_HUMAN Pituitary gland disorder [ICD-11: 5A60-5A61]
P14416 DRD2_HUMAN Postpartum haemorrhage [ICD-11: JA43]
P14416 DRD2_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P14416 DRD2_HUMAN Pulmonary hypertension [ICD-11: BB01]
P14416 DRD2_HUMAN Schizophrenia [ICD-11: 6A20]
P14416 DRD2_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P14416 DRD2_HUMAN Substance abuse [ICD-11: 6C40]
P14416 DRD2_HUMAN Thyrotoxicosis [ICD-11: 5A02]
P14416 DRD2_HUMAN Type 2 diabetes mellitus [ICD-11: 5A11]
P14416 DRD2_HUMAN Choreiform disorder [ICD-11: 8A01]
P14416 DRD2_HUMAN Lung cancer [ICD-11: 2C25]
P14416 DRD2_HUMAN Restless legs syndrome [ICD-11: 7A80]
P14416 DRD2_HUMAN Intellectual development disorder [ICD-11: LD90]
P14416 DRD2_HUMAN Brain cancer [ICD-11: 2A00]
P14416 DRD2_HUMAN Carcinoid syndrome [ICD-11: 5B10]
P14416 DRD2_HUMAN Chronic kidney disease [ICD-11: GB61]
P14416 DRD2_HUMAN Endocrine gland neoplasm [ICD-11: 2F37]
P14416 DRD2_HUMAN Endometrial cancer [ICD-11: 2C76]
P14416 DRD2_HUMAN Gastroduodenal motor/secretory disorder [ICD-11: DA41]
P14416 DRD2_HUMAN Idiopathic interstitial pneumonitis [ICD-11: CB03]
P14416 DRD2_HUMAN Leukaemia [ICD-11: 2A60-2B33]
P14416 DRD2_HUMAN Lymphoma [ICD-11: 2A80-2A86]
P14416 DRD2_HUMAN Multiple myeloma [ICD-11: 2A83]
P14416 DRD2_HUMAN Pancreatic cancer [ICD-11: 2C10]
P14416 DRD2_HUMAN Psoriasis [ICD-11: EA90]
P14416 DRD2_HUMAN Respiratory infection [ICD-11: CA07-CA4Z]
P14416 DRD2_HUMAN Schizoaffective disorder [ICD-11: 6A21]
P14416 DRD2_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P14416 DRD2_HUMAN Stomach cancer [ICD-11: 2B72]
P14416 DRD2_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
P14416 DRD2_HUMAN Tonus and reflex abnormality [ICD-11: MB47]
P14416 DRD2_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P14416 DRD2_HUMAN Fatigue [ICD-11: MG22]
P14416 DRD2_HUMAN Bacterial infection [ICD-11: 1A00-1C4Z]
P14416 DRD2_HUMAN Chronic obstructive pulmonary disease [ICD-11: CA22]
P14416 DRD2_HUMAN Indeterminate colitis [ICD-11: DD72]
P14416 DRD2_HUMAN Nicotine use disorder [ICD-11: 6C4A]
P14416 DRD2_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
P14416 DRD2_HUMAN Unspecific substance use disorder [ICD-11: 6C4Z]
P14416 DRD2_HUMAN Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z]
P14416 DRD2_HUMAN Thrombocytopenia [ICD-11: 3B64]
P14416 DRD2_HUMAN Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z]
P14416 DRD2_HUMAN Alzheimer disease [ICD-11: 8A20]
P14416 DRD2_HUMAN Asthma [ICD-11: CA23]
P14416 DRD2_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P14416 DRD2_HUMAN Bipolar disorder [ICD-11: 6A60]
P14416 DRD2_HUMAN Breathing abnormality [ICD-11: MD11]
P14416 DRD2_HUMAN Cardiovascular disease [ICD-11: BA00-BE2Z]
P14416 DRD2_HUMAN Cerebral ischaemia [ICD-11: 8B1Z]
P14416 DRD2_HUMAN Depression [ICD-11: 6A70-6A7Z]
P14416 DRD2_HUMAN Digestive system disease [ICD-11: DE2Z]
P14416 DRD2_HUMAN Essential hypertension [ICD-11: BA00]
P14416 DRD2_HUMAN Faecal incontinence [ICD-11: ME07]
P14416 DRD2_HUMAN Fibrosis [ICD-11: GA14-GC01]
P14416 DRD2_HUMAN Gangrene [ICD-11: MC85]
P14416 DRD2_HUMAN General pain disorder [ICD-11: 8E43]
P14416 DRD2_HUMAN Glaucoma [ICD-11: 9C61]
P14416 DRD2_HUMAN Heart failure [ICD-11: BD10-BD1Z]
P14416 DRD2_HUMAN Hyperaemia [ICD-11: 9A61-9B7Y]
P14416 DRD2_HUMAN Hypertension [ICD-11: BA00-BA04]
P14416 DRD2_HUMAN Hypotension [ICD-11: BA20-BA21]
P14416 DRD2_HUMAN Inborn porphyrin/heme metabolism error [ICD-11: 5C58]
P14416 DRD2_HUMAN Insomnia [ICD-11: 7A00-7A0Z]
P14416 DRD2_HUMAN Itching [ICD-11: 1F28-1G07]
P14416 DRD2_HUMAN Migraine [ICD-11: 8A80]
P14416 DRD2_HUMAN Nausea/vomiting [ICD-11: MD90]
P14416 DRD2_HUMAN Pain [ICD-11: MG30-MG3Z]
P14416 DRD2_HUMAN Parkinsonism [ICD-11: 8A00]
P14416 DRD2_HUMAN Pituitary gland disorder [ICD-11: 5A60-5A61]
P14416 DRD2_HUMAN Postpartum haemorrhage [ICD-11: JA43]
P14416 DRD2_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P14416 DRD2_HUMAN Pulmonary hypertension [ICD-11: BB01]
P14416 DRD2_HUMAN Schizophrenia [ICD-11: 6A20]
P14416 DRD2_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P14416 DRD2_HUMAN Substance abuse [ICD-11: 6C40]
P14416 DRD2_HUMAN Thyrotoxicosis [ICD-11: 5A02]
P14416 DRD2_HUMAN Type 2 diabetes mellitus [ICD-11: 5A11]
P14416 DRD2_HUMAN Choreiform disorder [ICD-11: 8A01]
P14416 DRD2_HUMAN Lung cancer [ICD-11: 2C25]
P14416 DRD2_HUMAN Restless legs syndrome [ICD-11: 7A80]
P14416 DRD2_HUMAN Intellectual development disorder [ICD-11: LD90]
P14416 DRD2_HUMAN Brain cancer [ICD-11: 2A00]
P14416 DRD2_HUMAN Carcinoid syndrome [ICD-11: 5B10]
P14416 DRD2_HUMAN Chronic kidney disease [ICD-11: GB61]
P14416 DRD2_HUMAN Endocrine gland neoplasm [ICD-11: 2F37]
P14416 DRD2_HUMAN Endometrial cancer [ICD-11: 2C76]
P14416 DRD2_HUMAN Gastroduodenal motor/secretory disorder [ICD-11: DA41]
P14416 DRD2_HUMAN Idiopathic interstitial pneumonitis [ICD-11: CB03]
P14416 DRD2_HUMAN Leukaemia [ICD-11: 2A60-2B33]
P14416 DRD2_HUMAN Lymphoma [ICD-11: 2A80-2A86]
P14416 DRD2_HUMAN Multiple myeloma [ICD-11: 2A83]
P14416 DRD2_HUMAN Pancreatic cancer [ICD-11: 2C10]
P14416 DRD2_HUMAN Psoriasis [ICD-11: EA90]
P14416 DRD2_HUMAN Respiratory infection [ICD-11: CA07-CA4Z]
P14416 DRD2_HUMAN Schizoaffective disorder [ICD-11: 6A21]
P14416 DRD2_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P14416 DRD2_HUMAN Stomach cancer [ICD-11: 2B72]
P14416 DRD2_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
P14416 DRD2_HUMAN Tonus and reflex abnormality [ICD-11: MB47]
P14416 DRD2_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P14416 DRD2_HUMAN Fatigue [ICD-11: MG22]
P14416 DRD2_HUMAN Bacterial infection [ICD-11: 1A00-1C4Z]
P14416 DRD2_HUMAN Chronic obstructive pulmonary disease [ICD-11: CA22]
P14416 DRD2_HUMAN Indeterminate colitis [ICD-11: DD72]
P14416 DRD2_HUMAN Nicotine use disorder [ICD-11: 6C4A]
P14416 DRD2_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
P14416 DRD2_HUMAN Unspecific substance use disorder [ICD-11: 6C4Z]
P14416 DRD2_HUMAN Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z]
P14416 DRD2_HUMAN Thrombocytopenia [ICD-11: 3B64]
P18089 ADA2B_HUMAN Substance abuse [ICD-11: 6C40]
P18089 ADA2B_HUMAN General pain disorder [ICD-11: 8E43]
P18089 ADA2B_HUMAN Pain [ICD-11: MG30-MG3Z]
P18089 ADA2B_HUMAN Hypertension [ICD-11: BA00-BA04]
P18089 ADA2B_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P18089 ADA2B_HUMAN Substance abuse [ICD-11: 6C40]
P18089 ADA2B_HUMAN General pain disorder [ICD-11: 8E43]
P18089 ADA2B_HUMAN Pain [ICD-11: MG30-MG3Z]
P18089 ADA2B_HUMAN Hypertension [ICD-11: BA00-BA04]
P18089 ADA2B_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P18089 ADA2B_HUMAN Substance abuse [ICD-11: 6C40]
P18089 ADA2B_HUMAN General pain disorder [ICD-11: 8E43]
P18089 ADA2B_HUMAN Pain [ICD-11: MG30-MG3Z]
P18089 ADA2B_HUMAN Hypertension [ICD-11: BA00-BA04]
P18089 ADA2B_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P18089 ADA2B_HUMAN Substance abuse [ICD-11: 6C40]
P18089 ADA2B_HUMAN General pain disorder [ICD-11: 8E43]
P18089 ADA2B_HUMAN Pain [ICD-11: MG30-MG3Z]
P18089 ADA2B_HUMAN Hypertension [ICD-11: BA00-BA04]
P18089 ADA2B_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P18089 ADA2B_HUMAN Substance abuse [ICD-11: 6C40]
P18089 ADA2B_HUMAN General pain disorder [ICD-11: 8E43]
P18089 ADA2B_HUMAN Pain [ICD-11: MG30-MG3Z]
P18089 ADA2B_HUMAN Hypertension [ICD-11: BA00-BA04]
P18089 ADA2B_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P18089 ADA2B_HUMAN Substance abuse [ICD-11: 6C40]
P18089 ADA2B_HUMAN General pain disorder [ICD-11: 8E43]
P18089 ADA2B_HUMAN Pain [ICD-11: MG30-MG3Z]
P18089 ADA2B_HUMAN Hypertension [ICD-11: BA00-BA04]
P18089 ADA2B_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P18089 ADA2B_HUMAN Substance abuse [ICD-11: 6C40]
P18089 ADA2B_HUMAN General pain disorder [ICD-11: 8E43]
P18089 ADA2B_HUMAN Pain [ICD-11: MG30-MG3Z]
P18089 ADA2B_HUMAN Hypertension [ICD-11: BA00-BA04]
P18089 ADA2B_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P18089 ADA2B_HUMAN Substance abuse [ICD-11: 6C40]
P18089 ADA2B_HUMAN General pain disorder [ICD-11: 8E43]
P18089 ADA2B_HUMAN Pain [ICD-11: MG30-MG3Z]
P18089 ADA2B_HUMAN Hypertension [ICD-11: BA00-BA04]
P18089 ADA2B_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P18089 ADA2B_HUMAN Substance abuse [ICD-11: 6C40]
P18089 ADA2B_HUMAN General pain disorder [ICD-11: 8E43]
P18089 ADA2B_HUMAN Pain [ICD-11: MG30-MG3Z]
P18089 ADA2B_HUMAN Hypertension [ICD-11: BA00-BA04]
P18089 ADA2B_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P18089 ADA2B_HUMAN Substance abuse [ICD-11: 6C40]
P18089 ADA2B_HUMAN General pain disorder [ICD-11: 8E43]
P18089 ADA2B_HUMAN Pain [ICD-11: MG30-MG3Z]
P18089 ADA2B_HUMAN Hypertension [ICD-11: BA00-BA04]
P18089 ADA2B_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P18825 ADA2C_HUMAN Glaucoma [ICD-11: 9C61]
P18825 ADA2C_HUMAN Herpes simplex infection [ICD-11: 1F00]
P18825 ADA2C_HUMAN Hypertension [ICD-11: BA00-BA04]
P18825 ADA2C_HUMAN Hypotension [ICD-11: BA20-BA21]
P18825 ADA2C_HUMAN Obesity [ICD-11: 5B80-5B81]
P18825 ADA2C_HUMAN Substance abuse [ICD-11: 6C40]
P18825 ADA2C_HUMAN Vasomotor/allergic rhinitis [ICD-11: CA08]
P18825 ADA2C_HUMAN Chronic pain [ICD-11: MG30]
P18825 ADA2C_HUMAN Dissociative neurological symptom disorder [ICD-11: 6B60]
P18825 ADA2C_HUMAN Post-traumatic stress disorder [ICD-11: 6B40]
P18825 ADA2C_HUMAN Alzheimer disease [ICD-11: 8A20]
P18825 ADA2C_HUMAN Chronic arterial occlusive disease [ICD-11: BD4Z]
P18825 ADA2C_HUMAN Chronic kidney disease [ICD-11: GB61]
P18825 ADA2C_HUMAN General pain disorder [ICD-11: 8E43]
P18825 ADA2C_HUMAN Non-specific cutaneous vascular sympton [ICD-11: ME64]
P18825 ADA2C_HUMAN Pain [ICD-11: MG30-MG3Z]
P18825 ADA2C_HUMAN Peptic ulcer [ICD-11: DA61]
P18825 ADA2C_HUMAN Depression [ICD-11: 6A70-6A7Z]
P18825 ADA2C_HUMAN Heart failure [ICD-11: BD10-BD1Z]
P18825 ADA2C_HUMAN Orgasmic dysfunction [ICD-11: HA02]
P18825 ADA2C_HUMAN Acute diabete complication [ICD-11: 5A2Y]
P18825 ADA2C_HUMAN Prostate disease [ICD-11: GA91]
P18825 ADA2C_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P18825 ADA2C_HUMAN Coronavirus infection [ICD-11: 1D92]
P18825 ADA2C_HUMAN Asthma [ICD-11: CA23]
P18825 ADA2C_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P18825 ADA2C_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P18825 ADA2C_HUMAN Unspecific body region injury [ICD-11: ND56]
P18825 ADA2C_HUMAN Unspecific substance harmful effect [ICD-11: NE6Z]
P18825 ADA2C_HUMAN Glaucoma [ICD-11: 9C61]
P18825 ADA2C_HUMAN Herpes simplex infection [ICD-11: 1F00]
P18825 ADA2C_HUMAN Hypertension [ICD-11: BA00-BA04]
P18825 ADA2C_HUMAN Hypotension [ICD-11: BA20-BA21]
P18825 ADA2C_HUMAN Obesity [ICD-11: 5B80-5B81]
P18825 ADA2C_HUMAN Substance abuse [ICD-11: 6C40]
P18825 ADA2C_HUMAN Vasomotor/allergic rhinitis [ICD-11: CA08]
P18825 ADA2C_HUMAN Chronic pain [ICD-11: MG30]
P18825 ADA2C_HUMAN Dissociative neurological symptom disorder [ICD-11: 6B60]
P18825 ADA2C_HUMAN Post-traumatic stress disorder [ICD-11: 6B40]
P18825 ADA2C_HUMAN Alzheimer disease [ICD-11: 8A20]
P18825 ADA2C_HUMAN Chronic arterial occlusive disease [ICD-11: BD4Z]
P18825 ADA2C_HUMAN Chronic kidney disease [ICD-11: GB61]
P18825 ADA2C_HUMAN General pain disorder [ICD-11: 8E43]
P18825 ADA2C_HUMAN Non-specific cutaneous vascular sympton [ICD-11: ME64]
P18825 ADA2C_HUMAN Pain [ICD-11: MG30-MG3Z]
P18825 ADA2C_HUMAN Peptic ulcer [ICD-11: DA61]
P18825 ADA2C_HUMAN Depression [ICD-11: 6A70-6A7Z]
P18825 ADA2C_HUMAN Heart failure [ICD-11: BD10-BD1Z]
P18825 ADA2C_HUMAN Orgasmic dysfunction [ICD-11: HA02]
P18825 ADA2C_HUMAN Acute diabete complication [ICD-11: 5A2Y]
P18825 ADA2C_HUMAN Prostate disease [ICD-11: GA91]
P18825 ADA2C_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P18825 ADA2C_HUMAN Coronavirus infection [ICD-11: 1D92]
P18825 ADA2C_HUMAN Asthma [ICD-11: CA23]
P18825 ADA2C_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P18825 ADA2C_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P18825 ADA2C_HUMAN Unspecific body region injury [ICD-11: ND56]
P18825 ADA2C_HUMAN Unspecific substance harmful effect [ICD-11: NE6Z]
P18825 ADA2C_HUMAN Glaucoma [ICD-11: 9C61]
P18825 ADA2C_HUMAN Herpes simplex infection [ICD-11: 1F00]
P18825 ADA2C_HUMAN Hypertension [ICD-11: BA00-BA04]
P18825 ADA2C_HUMAN Hypotension [ICD-11: BA20-BA21]
P18825 ADA2C_HUMAN Obesity [ICD-11: 5B80-5B81]
P18825 ADA2C_HUMAN Substance abuse [ICD-11: 6C40]
P18825 ADA2C_HUMAN Vasomotor/allergic rhinitis [ICD-11: CA08]
P18825 ADA2C_HUMAN Chronic pain [ICD-11: MG30]
P18825 ADA2C_HUMAN Dissociative neurological symptom disorder [ICD-11: 6B60]
P18825 ADA2C_HUMAN Post-traumatic stress disorder [ICD-11: 6B40]
P18825 ADA2C_HUMAN Alzheimer disease [ICD-11: 8A20]
P18825 ADA2C_HUMAN Chronic arterial occlusive disease [ICD-11: BD4Z]
P18825 ADA2C_HUMAN Chronic kidney disease [ICD-11: GB61]
P18825 ADA2C_HUMAN General pain disorder [ICD-11: 8E43]
P18825 ADA2C_HUMAN Non-specific cutaneous vascular sympton [ICD-11: ME64]
P18825 ADA2C_HUMAN Pain [ICD-11: MG30-MG3Z]
P18825 ADA2C_HUMAN Peptic ulcer [ICD-11: DA61]
P18825 ADA2C_HUMAN Depression [ICD-11: 6A70-6A7Z]
P18825 ADA2C_HUMAN Heart failure [ICD-11: BD10-BD1Z]
P18825 ADA2C_HUMAN Orgasmic dysfunction [ICD-11: HA02]
P18825 ADA2C_HUMAN Acute diabete complication [ICD-11: 5A2Y]
P18825 ADA2C_HUMAN Prostate disease [ICD-11: GA91]
P18825 ADA2C_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P18825 ADA2C_HUMAN Coronavirus infection [ICD-11: 1D92]
P18825 ADA2C_HUMAN Asthma [ICD-11: CA23]
P18825 ADA2C_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P18825 ADA2C_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P18825 ADA2C_HUMAN Unspecific body region injury [ICD-11: ND56]
P18825 ADA2C_HUMAN Unspecific substance harmful effect [ICD-11: NE6Z]
P18825 ADA2C_HUMAN Glaucoma [ICD-11: 9C61]
P18825 ADA2C_HUMAN Herpes simplex infection [ICD-11: 1F00]
P18825 ADA2C_HUMAN Hypertension [ICD-11: BA00-BA04]
P18825 ADA2C_HUMAN Hypotension [ICD-11: BA20-BA21]
P18825 ADA2C_HUMAN Obesity [ICD-11: 5B80-5B81]
P18825 ADA2C_HUMAN Substance abuse [ICD-11: 6C40]
P18825 ADA2C_HUMAN Vasomotor/allergic rhinitis [ICD-11: CA08]
P18825 ADA2C_HUMAN Chronic pain [ICD-11: MG30]
P18825 ADA2C_HUMAN Dissociative neurological symptom disorder [ICD-11: 6B60]
P18825 ADA2C_HUMAN Post-traumatic stress disorder [ICD-11: 6B40]
P18825 ADA2C_HUMAN Alzheimer disease [ICD-11: 8A20]
P18825 ADA2C_HUMAN Chronic arterial occlusive disease [ICD-11: BD4Z]
P18825 ADA2C_HUMAN Chronic kidney disease [ICD-11: GB61]
P18825 ADA2C_HUMAN General pain disorder [ICD-11: 8E43]
P18825 ADA2C_HUMAN Non-specific cutaneous vascular sympton [ICD-11: ME64]
P18825 ADA2C_HUMAN Pain [ICD-11: MG30-MG3Z]
P18825 ADA2C_HUMAN Peptic ulcer [ICD-11: DA61]
P18825 ADA2C_HUMAN Depression [ICD-11: 6A70-6A7Z]
P18825 ADA2C_HUMAN Heart failure [ICD-11: BD10-BD1Z]
P18825 ADA2C_HUMAN Orgasmic dysfunction [ICD-11: HA02]
P18825 ADA2C_HUMAN Acute diabete complication [ICD-11: 5A2Y]
P18825 ADA2C_HUMAN Prostate disease [ICD-11: GA91]
P18825 ADA2C_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P18825 ADA2C_HUMAN Coronavirus infection [ICD-11: 1D92]
P18825 ADA2C_HUMAN Asthma [ICD-11: CA23]
P18825 ADA2C_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P18825 ADA2C_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P18825 ADA2C_HUMAN Unspecific body region injury [ICD-11: ND56]
P18825 ADA2C_HUMAN Unspecific substance harmful effect [ICD-11: NE6Z]
P18825 ADA2C_HUMAN Glaucoma [ICD-11: 9C61]
P18825 ADA2C_HUMAN Herpes simplex infection [ICD-11: 1F00]
P18825 ADA2C_HUMAN Hypertension [ICD-11: BA00-BA04]
P18825 ADA2C_HUMAN Hypotension [ICD-11: BA20-BA21]
P18825 ADA2C_HUMAN Obesity [ICD-11: 5B80-5B81]
P18825 ADA2C_HUMAN Substance abuse [ICD-11: 6C40]
P18825 ADA2C_HUMAN Vasomotor/allergic rhinitis [ICD-11: CA08]
P18825 ADA2C_HUMAN Chronic pain [ICD-11: MG30]
P18825 ADA2C_HUMAN Dissociative neurological symptom disorder [ICD-11: 6B60]
P18825 ADA2C_HUMAN Post-traumatic stress disorder [ICD-11: 6B40]
P18825 ADA2C_HUMAN Alzheimer disease [ICD-11: 8A20]
P18825 ADA2C_HUMAN Chronic arterial occlusive disease [ICD-11: BD4Z]
P18825 ADA2C_HUMAN Chronic kidney disease [ICD-11: GB61]
P18825 ADA2C_HUMAN General pain disorder [ICD-11: 8E43]
P18825 ADA2C_HUMAN Non-specific cutaneous vascular sympton [ICD-11: ME64]
P18825 ADA2C_HUMAN Pain [ICD-11: MG30-MG3Z]
P18825 ADA2C_HUMAN Peptic ulcer [ICD-11: DA61]
P18825 ADA2C_HUMAN Depression [ICD-11: 6A70-6A7Z]
P18825 ADA2C_HUMAN Heart failure [ICD-11: BD10-BD1Z]
P18825 ADA2C_HUMAN Orgasmic dysfunction [ICD-11: HA02]
P18825 ADA2C_HUMAN Acute diabete complication [ICD-11: 5A2Y]
P18825 ADA2C_HUMAN Prostate disease [ICD-11: GA91]
P18825 ADA2C_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P18825 ADA2C_HUMAN Coronavirus infection [ICD-11: 1D92]
P18825 ADA2C_HUMAN Asthma [ICD-11: CA23]
P18825 ADA2C_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P18825 ADA2C_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P18825 ADA2C_HUMAN Unspecific body region injury [ICD-11: ND56]
P18825 ADA2C_HUMAN Unspecific substance harmful effect [ICD-11: NE6Z]
P18825 ADA2C_HUMAN Glaucoma [ICD-11: 9C61]
P18825 ADA2C_HUMAN Herpes simplex infection [ICD-11: 1F00]
P18825 ADA2C_HUMAN Hypertension [ICD-11: BA00-BA04]
P18825 ADA2C_HUMAN Hypotension [ICD-11: BA20-BA21]
P18825 ADA2C_HUMAN Obesity [ICD-11: 5B80-5B81]
P18825 ADA2C_HUMAN Substance abuse [ICD-11: 6C40]
P18825 ADA2C_HUMAN Vasomotor/allergic rhinitis [ICD-11: CA08]
P18825 ADA2C_HUMAN Chronic pain [ICD-11: MG30]
P18825 ADA2C_HUMAN Dissociative neurological symptom disorder [ICD-11: 6B60]
P18825 ADA2C_HUMAN Post-traumatic stress disorder [ICD-11: 6B40]
P18825 ADA2C_HUMAN Alzheimer disease [ICD-11: 8A20]
P18825 ADA2C_HUMAN Chronic arterial occlusive disease [ICD-11: BD4Z]
P18825 ADA2C_HUMAN Chronic kidney disease [ICD-11: GB61]
P18825 ADA2C_HUMAN General pain disorder [ICD-11: 8E43]
P18825 ADA2C_HUMAN Non-specific cutaneous vascular sympton [ICD-11: ME64]
P18825 ADA2C_HUMAN Pain [ICD-11: MG30-MG3Z]
P18825 ADA2C_HUMAN Peptic ulcer [ICD-11: DA61]
P18825 ADA2C_HUMAN Depression [ICD-11: 6A70-6A7Z]
P18825 ADA2C_HUMAN Heart failure [ICD-11: BD10-BD1Z]
P18825 ADA2C_HUMAN Orgasmic dysfunction [ICD-11: HA02]
P18825 ADA2C_HUMAN Acute diabete complication [ICD-11: 5A2Y]
P18825 ADA2C_HUMAN Prostate disease [ICD-11: GA91]
P18825 ADA2C_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P18825 ADA2C_HUMAN Coronavirus infection [ICD-11: 1D92]
P18825 ADA2C_HUMAN Asthma [ICD-11: CA23]
P18825 ADA2C_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P18825 ADA2C_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P18825 ADA2C_HUMAN Unspecific body region injury [ICD-11: ND56]
P18825 ADA2C_HUMAN Unspecific substance harmful effect [ICD-11: NE6Z]
P18825 ADA2C_HUMAN Glaucoma [ICD-11: 9C61]
P18825 ADA2C_HUMAN Herpes simplex infection [ICD-11: 1F00]
P18825 ADA2C_HUMAN Hypertension [ICD-11: BA00-BA04]
P18825 ADA2C_HUMAN Hypotension [ICD-11: BA20-BA21]
P18825 ADA2C_HUMAN Obesity [ICD-11: 5B80-5B81]
P18825 ADA2C_HUMAN Substance abuse [ICD-11: 6C40]
P18825 ADA2C_HUMAN Vasomotor/allergic rhinitis [ICD-11: CA08]
P18825 ADA2C_HUMAN Chronic pain [ICD-11: MG30]
P18825 ADA2C_HUMAN Dissociative neurological symptom disorder [ICD-11: 6B60]
P18825 ADA2C_HUMAN Post-traumatic stress disorder [ICD-11: 6B40]
P18825 ADA2C_HUMAN Alzheimer disease [ICD-11: 8A20]
P18825 ADA2C_HUMAN Chronic arterial occlusive disease [ICD-11: BD4Z]
P18825 ADA2C_HUMAN Chronic kidney disease [ICD-11: GB61]
P18825 ADA2C_HUMAN General pain disorder [ICD-11: 8E43]
P18825 ADA2C_HUMAN Non-specific cutaneous vascular sympton [ICD-11: ME64]
P18825 ADA2C_HUMAN Pain [ICD-11: MG30-MG3Z]
P18825 ADA2C_HUMAN Peptic ulcer [ICD-11: DA61]
P18825 ADA2C_HUMAN Depression [ICD-11: 6A70-6A7Z]
P18825 ADA2C_HUMAN Heart failure [ICD-11: BD10-BD1Z]
P18825 ADA2C_HUMAN Orgasmic dysfunction [ICD-11: HA02]
P18825 ADA2C_HUMAN Acute diabete complication [ICD-11: 5A2Y]
P18825 ADA2C_HUMAN Prostate disease [ICD-11: GA91]
P18825 ADA2C_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P18825 ADA2C_HUMAN Coronavirus infection [ICD-11: 1D92]
P18825 ADA2C_HUMAN Asthma [ICD-11: CA23]
P18825 ADA2C_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P18825 ADA2C_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P18825 ADA2C_HUMAN Unspecific body region injury [ICD-11: ND56]
P18825 ADA2C_HUMAN Unspecific substance harmful effect [ICD-11: NE6Z]
P18825 ADA2C_HUMAN Glaucoma [ICD-11: 9C61]
P18825 ADA2C_HUMAN Herpes simplex infection [ICD-11: 1F00]
P18825 ADA2C_HUMAN Hypertension [ICD-11: BA00-BA04]
P18825 ADA2C_HUMAN Hypotension [ICD-11: BA20-BA21]
P18825 ADA2C_HUMAN Obesity [ICD-11: 5B80-5B81]
P18825 ADA2C_HUMAN Substance abuse [ICD-11: 6C40]
P18825 ADA2C_HUMAN Vasomotor/allergic rhinitis [ICD-11: CA08]
P18825 ADA2C_HUMAN Chronic pain [ICD-11: MG30]
P18825 ADA2C_HUMAN Dissociative neurological symptom disorder [ICD-11: 6B60]
P18825 ADA2C_HUMAN Post-traumatic stress disorder [ICD-11: 6B40]
P18825 ADA2C_HUMAN Alzheimer disease [ICD-11: 8A20]
P18825 ADA2C_HUMAN Chronic arterial occlusive disease [ICD-11: BD4Z]
P18825 ADA2C_HUMAN Chronic kidney disease [ICD-11: GB61]
P18825 ADA2C_HUMAN General pain disorder [ICD-11: 8E43]
P18825 ADA2C_HUMAN Non-specific cutaneous vascular sympton [ICD-11: ME64]
P18825 ADA2C_HUMAN Pain [ICD-11: MG30-MG3Z]
P18825 ADA2C_HUMAN Peptic ulcer [ICD-11: DA61]
P18825 ADA2C_HUMAN Depression [ICD-11: 6A70-6A7Z]
P18825 ADA2C_HUMAN Heart failure [ICD-11: BD10-BD1Z]
P18825 ADA2C_HUMAN Orgasmic dysfunction [ICD-11: HA02]
P18825 ADA2C_HUMAN Acute diabete complication [ICD-11: 5A2Y]
P18825 ADA2C_HUMAN Prostate disease [ICD-11: GA91]
P18825 ADA2C_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P18825 ADA2C_HUMAN Coronavirus infection [ICD-11: 1D92]
P18825 ADA2C_HUMAN Asthma [ICD-11: CA23]
P18825 ADA2C_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P18825 ADA2C_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P18825 ADA2C_HUMAN Unspecific body region injury [ICD-11: ND56]
P18825 ADA2C_HUMAN Unspecific substance harmful effect [ICD-11: NE6Z]
P18825 ADA2C_HUMAN Glaucoma [ICD-11: 9C61]
P18825 ADA2C_HUMAN Herpes simplex infection [ICD-11: 1F00]
P18825 ADA2C_HUMAN Hypertension [ICD-11: BA00-BA04]
P18825 ADA2C_HUMAN Hypotension [ICD-11: BA20-BA21]
P18825 ADA2C_HUMAN Obesity [ICD-11: 5B80-5B81]
P18825 ADA2C_HUMAN Substance abuse [ICD-11: 6C40]
P18825 ADA2C_HUMAN Vasomotor/allergic rhinitis [ICD-11: CA08]
P18825 ADA2C_HUMAN Chronic pain [ICD-11: MG30]
P18825 ADA2C_HUMAN Dissociative neurological symptom disorder [ICD-11: 6B60]
P18825 ADA2C_HUMAN Post-traumatic stress disorder [ICD-11: 6B40]
P18825 ADA2C_HUMAN Alzheimer disease [ICD-11: 8A20]
P18825 ADA2C_HUMAN Chronic arterial occlusive disease [ICD-11: BD4Z]
P18825 ADA2C_HUMAN Chronic kidney disease [ICD-11: GB61]
P18825 ADA2C_HUMAN General pain disorder [ICD-11: 8E43]
P18825 ADA2C_HUMAN Non-specific cutaneous vascular sympton [ICD-11: ME64]
P18825 ADA2C_HUMAN Pain [ICD-11: MG30-MG3Z]
P18825 ADA2C_HUMAN Peptic ulcer [ICD-11: DA61]
P18825 ADA2C_HUMAN Depression [ICD-11: 6A70-6A7Z]
P18825 ADA2C_HUMAN Heart failure [ICD-11: BD10-BD1Z]
P18825 ADA2C_HUMAN Orgasmic dysfunction [ICD-11: HA02]
P18825 ADA2C_HUMAN Acute diabete complication [ICD-11: 5A2Y]
P18825 ADA2C_HUMAN Prostate disease [ICD-11: GA91]
P18825 ADA2C_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P18825 ADA2C_HUMAN Coronavirus infection [ICD-11: 1D92]
P18825 ADA2C_HUMAN Asthma [ICD-11: CA23]
P18825 ADA2C_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P18825 ADA2C_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P18825 ADA2C_HUMAN Unspecific body region injury [ICD-11: ND56]
P18825 ADA2C_HUMAN Unspecific substance harmful effect [ICD-11: NE6Z]
P18825 ADA2C_HUMAN Glaucoma [ICD-11: 9C61]
P18825 ADA2C_HUMAN Herpes simplex infection [ICD-11: 1F00]
P18825 ADA2C_HUMAN Hypertension [ICD-11: BA00-BA04]
P18825 ADA2C_HUMAN Hypotension [ICD-11: BA20-BA21]
P18825 ADA2C_HUMAN Obesity [ICD-11: 5B80-5B81]
P18825 ADA2C_HUMAN Substance abuse [ICD-11: 6C40]
P18825 ADA2C_HUMAN Vasomotor/allergic rhinitis [ICD-11: CA08]
P18825 ADA2C_HUMAN Chronic pain [ICD-11: MG30]
P18825 ADA2C_HUMAN Dissociative neurological symptom disorder [ICD-11: 6B60]
P18825 ADA2C_HUMAN Post-traumatic stress disorder [ICD-11: 6B40]
P18825 ADA2C_HUMAN Alzheimer disease [ICD-11: 8A20]
P18825 ADA2C_HUMAN Chronic arterial occlusive disease [ICD-11: BD4Z]
P18825 ADA2C_HUMAN Chronic kidney disease [ICD-11: GB61]
P18825 ADA2C_HUMAN General pain disorder [ICD-11: 8E43]
P18825 ADA2C_HUMAN Non-specific cutaneous vascular sympton [ICD-11: ME64]
P18825 ADA2C_HUMAN Pain [ICD-11: MG30-MG3Z]
P18825 ADA2C_HUMAN Peptic ulcer [ICD-11: DA61]
P18825 ADA2C_HUMAN Depression [ICD-11: 6A70-6A7Z]
P18825 ADA2C_HUMAN Heart failure [ICD-11: BD10-BD1Z]
P18825 ADA2C_HUMAN Orgasmic dysfunction [ICD-11: HA02]
P18825 ADA2C_HUMAN Acute diabete complication [ICD-11: 5A2Y]
P18825 ADA2C_HUMAN Prostate disease [ICD-11: GA91]
P18825 ADA2C_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P18825 ADA2C_HUMAN Coronavirus infection [ICD-11: 1D92]
P18825 ADA2C_HUMAN Asthma [ICD-11: CA23]
P18825 ADA2C_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P18825 ADA2C_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P18825 ADA2C_HUMAN Unspecific body region injury [ICD-11: ND56]
P18825 ADA2C_HUMAN Unspecific substance harmful effect [ICD-11: NE6Z]
P21554 CNR1_HUMAN Anorexia nervosa [ICD-11: 6B80]
P21554 CNR1_HUMAN Insomnia [ICD-11: 7A00-7A0Z]
P21554 CNR1_HUMAN Nausea/vomiting [ICD-11: MD90]
P21554 CNR1_HUMAN Obesity [ICD-11: 5B80-5B81]
P21554 CNR1_HUMAN Nicotine use disorder [ICD-11: 6C4A]
P21554 CNR1_HUMAN Urinary tract infection [ICD-11: GC08]
P21554 CNR1_HUMAN Cannabis use disorder [ICD-11: 6C41]
P21554 CNR1_HUMAN Chronic kidney disease [ICD-11: GB61]
P21554 CNR1_HUMAN Colorectal cancer [ICD-11: 2B91]
P21554 CNR1_HUMAN Inborn lipid metabolism error [ICD-11: 5C52]
P21554 CNR1_HUMAN Pain [ICD-11: MG30-MG3Z]
P21554 CNR1_HUMAN Acute diabete complication [ICD-11: 5A2Y]
P21554 CNR1_HUMAN Metabolic disorder [ICD-11: 5C50-5D2Z]
P21554 CNR1_HUMAN Type 2 diabetes mellitus [ICD-11: 5A11]
P21554 CNR1_HUMAN General pain disorder [ICD-11: 8E43]
P21554 CNR1_HUMAN Low bone mass disorder [ICD-11: FB83]
P21554 CNR1_HUMAN Prostate cancer [ICD-11: 2C82]
P21554 CNR1_HUMAN Ischemia [ICD-11: 8B10-8B11]
P21554 CNR1_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P21554 CNR1_HUMAN Zoster [ICD-11: 1E91]
P21554 CNR1_HUMAN Cerebral ischaemia [ICD-11: 8B1Z]
P21554 CNR1_HUMAN Hypertension [ICD-11: BA00-BA04]
P21554 CNR1_HUMAN Schizophrenia [ICD-11: 6A20]
P21554 CNR1_HUMAN Central nervous system disease [ICD-11: 8A04-8D87]
P21554 CNR1_HUMAN Ovarian cancer [ICD-11: 2C73]
P21554 CNR1_HUMAN Psychoactive substances use disorder [ICD-11: 6C4G]
P21728 DRD1_HUMAN Abortion [ICD-11: JA00]
P21728 DRD1_HUMAN Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z]
P21728 DRD1_HUMAN Hypertension [ICD-11: BA00-BA04]
P21728 DRD1_HUMAN Parkinsonism [ICD-11: 8A00]
P21728 DRD1_HUMAN Cocaine use disorder [ICD-11: 6C45]
P21728 DRD1_HUMAN Schizophrenia [ICD-11: 6A20]
P21728 DRD1_HUMAN Tic disorder [ICD-11: 8A05]
P21728 DRD1_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P21728 DRD1_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P21728 DRD1_HUMAN Mild neurocognitive disorder [ICD-11: 6D71]
P21728 DRD1_HUMAN Pain [ICD-11: MG30-MG3Z]
P21728 DRD1_HUMAN Glaucoma [ICD-11: 9C61]
P21728 DRD1_HUMAN Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z]
P21728 DRD1_HUMAN Type 2 diabetes mellitus [ICD-11: 5A11]
P21728 DRD1_HUMAN Unspecific substance use disorder [ICD-11: 6C4Z]
P21728 DRD1_HUMAN Abortion [ICD-11: JA00]
P21728 DRD1_HUMAN Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z]
P21728 DRD1_HUMAN Hypertension [ICD-11: BA00-BA04]
P21728 DRD1_HUMAN Parkinsonism [ICD-11: 8A00]
P21728 DRD1_HUMAN Cocaine use disorder [ICD-11: 6C45]
P21728 DRD1_HUMAN Schizophrenia [ICD-11: 6A20]
P21728 DRD1_HUMAN Tic disorder [ICD-11: 8A05]
P21728 DRD1_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P21728 DRD1_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P21728 DRD1_HUMAN Mild neurocognitive disorder [ICD-11: 6D71]
P21728 DRD1_HUMAN Pain [ICD-11: MG30-MG3Z]
P21728 DRD1_HUMAN Glaucoma [ICD-11: 9C61]
P21728 DRD1_HUMAN Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z]
P21728 DRD1_HUMAN Type 2 diabetes mellitus [ICD-11: 5A11]
P21728 DRD1_HUMAN Unspecific substance use disorder [ICD-11: 6C4Z]
P23975 SC6A2_HUMAN Acute pain [ICD-11: MG31]
P23975 SC6A2_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P23975 SC6A2_HUMAN Binge eating disorder [ICD-11: 6B82]
P23975 SC6A2_HUMAN Chronic pain [ICD-11: MG30]
P23975 SC6A2_HUMAN Corneal disease [ICD-11: 9A76-9A78]
P23975 SC6A2_HUMAN Depression [ICD-11: 6A70-6A7Z]
P23975 SC6A2_HUMAN Glaucoma [ICD-11: 9C61]
P23975 SC6A2_HUMAN Migraine [ICD-11: 8A80]
P23975 SC6A2_HUMAN Mood disorder [ICD-11: 6A60-6E23]
P23975 SC6A2_HUMAN Nicotine use disorder [ICD-11: 6C4A]
P23975 SC6A2_HUMAN Obesity [ICD-11: 5B80-5B81]
P23975 SC6A2_HUMAN Pain [ICD-11: MG30-MG3Z]
P23975 SC6A2_HUMAN Stomach cancer [ICD-11: 2B72]
P23975 SC6A2_HUMAN General pain disorder [ICD-11: 8E43]
P23975 SC6A2_HUMAN Mild neurocognitive disorder [ICD-11: 6D71]
P23975 SC6A2_HUMAN Substance abuse [ICD-11: 6C40]
P23975 SC6A2_HUMAN Adrenal cancer [ICD-11: 2D11]
P23975 SC6A2_HUMAN Adrenomedullary hyperfunction [ICD-11: 5A75]
P23975 SC6A2_HUMAN Cocaine use disorder [ICD-11: 6C45]
P23975 SC6A2_HUMAN Fatigue [ICD-11: MG22]
P23975 SC6A2_HUMAN Heart failure [ICD-11: BD10-BD1Z]
P23975 SC6A2_HUMAN Orthostatic hypotension [ICD-11: BA21]
P23975 SC6A2_HUMAN Stomach disease [ICD-11: DA43-DA4Y]
P23975 SC6A2_HUMAN Dissociative neurological symptom disorder [ICD-11: 6B60]
P25100 ADA1D_HUMAN Glaucoma [ICD-11: 9C61]
P25100 ADA1D_HUMAN Heart failure [ICD-11: BD10-BD1Z]
P25100 ADA1D_HUMAN Hypertension [ICD-11: BA00-BA04]
P25100 ADA1D_HUMAN Prostate hyperplasia [ICD-11: GA90]
P25100 ADA1D_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P25100 ADA1D_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P25100 ADA1D_HUMAN Pain [ICD-11: MG30-MG3Z]
P25100 ADA1D_HUMAN Abnormal micturition [ICD-11: MF50]
P25100 ADA1D_HUMAN Acute diabete complication [ICD-11: 5A2Y]
P25100 ADA1D_HUMAN Chronic arterial occlusive disease [ICD-11: BD4Z]
P25100 ADA1D_HUMAN Prostate disease [ICD-11: GA91]
P25100 ADA1D_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P25100 ADA1D_HUMAN Glaucoma [ICD-11: 9C61]
P25100 ADA1D_HUMAN Heart failure [ICD-11: BD10-BD1Z]
P25100 ADA1D_HUMAN Hypertension [ICD-11: BA00-BA04]
P25100 ADA1D_HUMAN Prostate hyperplasia [ICD-11: GA90]
P25100 ADA1D_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P25100 ADA1D_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P25100 ADA1D_HUMAN Pain [ICD-11: MG30-MG3Z]
P25100 ADA1D_HUMAN Abnormal micturition [ICD-11: MF50]
P25100 ADA1D_HUMAN Acute diabete complication [ICD-11: 5A2Y]
P25100 ADA1D_HUMAN Chronic arterial occlusive disease [ICD-11: BD4Z]
P25100 ADA1D_HUMAN Prostate disease [ICD-11: GA91]
P25100 ADA1D_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P25100 ADA1D_HUMAN Glaucoma [ICD-11: 9C61]
P25100 ADA1D_HUMAN Heart failure [ICD-11: BD10-BD1Z]
P25100 ADA1D_HUMAN Hypertension [ICD-11: BA00-BA04]
P25100 ADA1D_HUMAN Prostate hyperplasia [ICD-11: GA90]
P25100 ADA1D_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P25100 ADA1D_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P25100 ADA1D_HUMAN Pain [ICD-11: MG30-MG3Z]
P25100 ADA1D_HUMAN Abnormal micturition [ICD-11: MF50]
P25100 ADA1D_HUMAN Acute diabete complication [ICD-11: 5A2Y]
P25100 ADA1D_HUMAN Chronic arterial occlusive disease [ICD-11: BD4Z]
P25100 ADA1D_HUMAN Prostate disease [ICD-11: GA91]
P25100 ADA1D_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P25100 ADA1D_HUMAN Glaucoma [ICD-11: 9C61]
P25100 ADA1D_HUMAN Heart failure [ICD-11: BD10-BD1Z]
P25100 ADA1D_HUMAN Hypertension [ICD-11: BA00-BA04]
P25100 ADA1D_HUMAN Prostate hyperplasia [ICD-11: GA90]
P25100 ADA1D_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P25100 ADA1D_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P25100 ADA1D_HUMAN Pain [ICD-11: MG30-MG3Z]
P25100 ADA1D_HUMAN Abnormal micturition [ICD-11: MF50]
P25100 ADA1D_HUMAN Acute diabete complication [ICD-11: 5A2Y]
P25100 ADA1D_HUMAN Chronic arterial occlusive disease [ICD-11: BD4Z]
P25100 ADA1D_HUMAN Prostate disease [ICD-11: GA91]
P25100 ADA1D_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P28223 5HT2A_HUMAN Acute diabete complication [ICD-11: 5A2Y]
P28223 5HT2A_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
P28223 5HT2A_HUMAN Cerebral ischaemia [ICD-11: 8B1Z]
P28223 5HT2A_HUMAN Mood disorder [ICD-11: 6A60-6E23]
P28223 5HT2A_HUMAN Parkinsonism [ICD-11: 8A00]
P28223 5HT2A_HUMAN Pituitary gland disorder [ICD-11: 5A60-5A61]
P28223 5HT2A_HUMAN Schizophrenia [ICD-11: 6A20]
P28223 5HT2A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P28223 5HT2A_HUMAN Chronic insomnia [ICD-11: 7A00]
P28223 5HT2A_HUMAN Chronic pain [ICD-11: MG30]
P28223 5HT2A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P28223 5HT2A_HUMAN Insomnia [ICD-11: 7A00-7A0Z]
P28223 5HT2A_HUMAN Post-traumatic stress disorder [ICD-11: 6B40]
P28223 5HT2A_HUMAN Sleep-wake disorder [ICD-11: 7A00-7B2Z]
P28223 5HT2A_HUMAN Alzheimer disease [ICD-11: 8A20]
P28223 5HT2A_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P28223 5HT2A_HUMAN Bipolar disorder [ICD-11: 6A60]
P28223 5HT2A_HUMAN Chronic kidney disease [ICD-11: GB61]
P28223 5HT2A_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P28223 5HT2A_HUMAN Glaucoma [ICD-11: 9C61]
P28223 5HT2A_HUMAN Idiopathic interstitial pneumonitis [ICD-11: CB03]
P28223 5HT2A_HUMAN Pancreatic cancer [ICD-11: 2C10]
P28223 5HT2A_HUMAN Schizoaffective disorder [ICD-11: 6A21]
P28223 5HT2A_HUMAN Social anxiety disorder [ICD-11: 6B04]
P28223 5HT2A_HUMAN Type 2 diabetes mellitus [ICD-11: 5A11]
P28223 5HT2A_HUMAN Cardiovascular disease [ICD-11: BA00-BE2Z]
P28223 5HT2A_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P28223 5HT2A_HUMAN Prostate hyperplasia [ICD-11: GA90]
P28223 5HT2A_HUMAN Addictive disorder [ICD-11: 6C50-6C5Z]
P28223 5HT2A_HUMAN Haemorrhoids [ICD-11: DB60]
P28223 5HT2A_HUMAN Hypertension [ICD-11: BA00-BA04]
P28223 5HT2A_HUMAN Migraine [ICD-11: 8A80]
P28223 5HT2A_HUMAN Pancreatitis [ICD-11: DC31-DC34]
P28223 5HT2A_HUMAN Substance abuse [ICD-11: 6C40]
P28223 5HT2A_HUMAN Central nervous system disease [ICD-11: 8A04-8D87]
P28223 5HT2A_HUMAN Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z]
P28223 5HT2A_HUMAN Acute diabete complication [ICD-11: 5A2Y]
P28223 5HT2A_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
P28223 5HT2A_HUMAN Cerebral ischaemia [ICD-11: 8B1Z]
P28223 5HT2A_HUMAN Mood disorder [ICD-11: 6A60-6E23]
P28223 5HT2A_HUMAN Parkinsonism [ICD-11: 8A00]
P28223 5HT2A_HUMAN Pituitary gland disorder [ICD-11: 5A60-5A61]
P28223 5HT2A_HUMAN Schizophrenia [ICD-11: 6A20]
P28223 5HT2A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P28223 5HT2A_HUMAN Chronic insomnia [ICD-11: 7A00]
P28223 5HT2A_HUMAN Chronic pain [ICD-11: MG30]
P28223 5HT2A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P28223 5HT2A_HUMAN Insomnia [ICD-11: 7A00-7A0Z]
P28223 5HT2A_HUMAN Post-traumatic stress disorder [ICD-11: 6B40]
P28223 5HT2A_HUMAN Sleep-wake disorder [ICD-11: 7A00-7B2Z]
P28223 5HT2A_HUMAN Alzheimer disease [ICD-11: 8A20]
P28223 5HT2A_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P28223 5HT2A_HUMAN Bipolar disorder [ICD-11: 6A60]
P28223 5HT2A_HUMAN Chronic kidney disease [ICD-11: GB61]
P28223 5HT2A_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P28223 5HT2A_HUMAN Glaucoma [ICD-11: 9C61]
P28223 5HT2A_HUMAN Idiopathic interstitial pneumonitis [ICD-11: CB03]
P28223 5HT2A_HUMAN Pancreatic cancer [ICD-11: 2C10]
P28223 5HT2A_HUMAN Schizoaffective disorder [ICD-11: 6A21]
P28223 5HT2A_HUMAN Social anxiety disorder [ICD-11: 6B04]
P28223 5HT2A_HUMAN Type 2 diabetes mellitus [ICD-11: 5A11]
P28223 5HT2A_HUMAN Cardiovascular disease [ICD-11: BA00-BE2Z]
P28223 5HT2A_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P28223 5HT2A_HUMAN Prostate hyperplasia [ICD-11: GA90]
P28223 5HT2A_HUMAN Addictive disorder [ICD-11: 6C50-6C5Z]
P28223 5HT2A_HUMAN Haemorrhoids [ICD-11: DB60]
P28223 5HT2A_HUMAN Hypertension [ICD-11: BA00-BA04]
P28223 5HT2A_HUMAN Migraine [ICD-11: 8A80]
P28223 5HT2A_HUMAN Pancreatitis [ICD-11: DC31-DC34]
P28223 5HT2A_HUMAN Substance abuse [ICD-11: 6C40]
P28223 5HT2A_HUMAN Central nervous system disease [ICD-11: 8A04-8D87]
P28223 5HT2A_HUMAN Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z]
P28223 5HT2A_HUMAN Acute diabete complication [ICD-11: 5A2Y]
P28223 5HT2A_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
P28223 5HT2A_HUMAN Cerebral ischaemia [ICD-11: 8B1Z]
P28223 5HT2A_HUMAN Mood disorder [ICD-11: 6A60-6E23]
P28223 5HT2A_HUMAN Parkinsonism [ICD-11: 8A00]
P28223 5HT2A_HUMAN Pituitary gland disorder [ICD-11: 5A60-5A61]
P28223 5HT2A_HUMAN Schizophrenia [ICD-11: 6A20]
P28223 5HT2A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P28223 5HT2A_HUMAN Chronic insomnia [ICD-11: 7A00]
P28223 5HT2A_HUMAN Chronic pain [ICD-11: MG30]
P28223 5HT2A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P28223 5HT2A_HUMAN Insomnia [ICD-11: 7A00-7A0Z]
P28223 5HT2A_HUMAN Post-traumatic stress disorder [ICD-11: 6B40]
P28223 5HT2A_HUMAN Sleep-wake disorder [ICD-11: 7A00-7B2Z]
P28223 5HT2A_HUMAN Alzheimer disease [ICD-11: 8A20]
P28223 5HT2A_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P28223 5HT2A_HUMAN Bipolar disorder [ICD-11: 6A60]
P28223 5HT2A_HUMAN Chronic kidney disease [ICD-11: GB61]
P28223 5HT2A_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P28223 5HT2A_HUMAN Glaucoma [ICD-11: 9C61]
P28223 5HT2A_HUMAN Idiopathic interstitial pneumonitis [ICD-11: CB03]
P28223 5HT2A_HUMAN Pancreatic cancer [ICD-11: 2C10]
P28223 5HT2A_HUMAN Schizoaffective disorder [ICD-11: 6A21]
P28223 5HT2A_HUMAN Social anxiety disorder [ICD-11: 6B04]
P28223 5HT2A_HUMAN Type 2 diabetes mellitus [ICD-11: 5A11]
P28223 5HT2A_HUMAN Cardiovascular disease [ICD-11: BA00-BE2Z]
P28223 5HT2A_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P28223 5HT2A_HUMAN Prostate hyperplasia [ICD-11: GA90]
P28223 5HT2A_HUMAN Addictive disorder [ICD-11: 6C50-6C5Z]
P28223 5HT2A_HUMAN Haemorrhoids [ICD-11: DB60]
P28223 5HT2A_HUMAN Hypertension [ICD-11: BA00-BA04]
P28223 5HT2A_HUMAN Migraine [ICD-11: 8A80]
P28223 5HT2A_HUMAN Pancreatitis [ICD-11: DC31-DC34]
P28223 5HT2A_HUMAN Substance abuse [ICD-11: 6C40]
P28223 5HT2A_HUMAN Central nervous system disease [ICD-11: 8A04-8D87]
P28223 5HT2A_HUMAN Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z]
P28223 5HT2A_HUMAN Acute diabete complication [ICD-11: 5A2Y]
P28223 5HT2A_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
P28223 5HT2A_HUMAN Cerebral ischaemia [ICD-11: 8B1Z]
P28223 5HT2A_HUMAN Mood disorder [ICD-11: 6A60-6E23]
P28223 5HT2A_HUMAN Parkinsonism [ICD-11: 8A00]
P28223 5HT2A_HUMAN Pituitary gland disorder [ICD-11: 5A60-5A61]
P28223 5HT2A_HUMAN Schizophrenia [ICD-11: 6A20]
P28223 5HT2A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P28223 5HT2A_HUMAN Chronic insomnia [ICD-11: 7A00]
P28223 5HT2A_HUMAN Chronic pain [ICD-11: MG30]
P28223 5HT2A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P28223 5HT2A_HUMAN Insomnia [ICD-11: 7A00-7A0Z]
P28223 5HT2A_HUMAN Post-traumatic stress disorder [ICD-11: 6B40]
P28223 5HT2A_HUMAN Sleep-wake disorder [ICD-11: 7A00-7B2Z]
P28223 5HT2A_HUMAN Alzheimer disease [ICD-11: 8A20]
P28223 5HT2A_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P28223 5HT2A_HUMAN Bipolar disorder [ICD-11: 6A60]
P28223 5HT2A_HUMAN Chronic kidney disease [ICD-11: GB61]
P28223 5HT2A_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P28223 5HT2A_HUMAN Glaucoma [ICD-11: 9C61]
P28223 5HT2A_HUMAN Idiopathic interstitial pneumonitis [ICD-11: CB03]
P28223 5HT2A_HUMAN Pancreatic cancer [ICD-11: 2C10]
P28223 5HT2A_HUMAN Schizoaffective disorder [ICD-11: 6A21]
P28223 5HT2A_HUMAN Social anxiety disorder [ICD-11: 6B04]
P28223 5HT2A_HUMAN Type 2 diabetes mellitus [ICD-11: 5A11]
P28223 5HT2A_HUMAN Cardiovascular disease [ICD-11: BA00-BE2Z]
P28223 5HT2A_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P28223 5HT2A_HUMAN Prostate hyperplasia [ICD-11: GA90]
P28223 5HT2A_HUMAN Addictive disorder [ICD-11: 6C50-6C5Z]
P28223 5HT2A_HUMAN Haemorrhoids [ICD-11: DB60]
P28223 5HT2A_HUMAN Hypertension [ICD-11: BA00-BA04]
P28223 5HT2A_HUMAN Migraine [ICD-11: 8A80]
P28223 5HT2A_HUMAN Pancreatitis [ICD-11: DC31-DC34]
P28223 5HT2A_HUMAN Substance abuse [ICD-11: 6C40]
P28223 5HT2A_HUMAN Central nervous system disease [ICD-11: 8A04-8D87]
P28223 5HT2A_HUMAN Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z]
P28335 5HT2C_HUMAN Depression [ICD-11: 6A70-6A7Z]
P28335 5HT2C_HUMAN Migraine [ICD-11: 8A80]
P28335 5HT2C_HUMAN Obesity [ICD-11: 5B80-5B81]
P28335 5HT2C_HUMAN Pain [ICD-11: MG30-MG3Z]
P28335 5HT2C_HUMAN Pituitary gland disorder [ICD-11: 5A60-5A61]
P28335 5HT2C_HUMAN Psychoactive substances use disorder [ICD-11: 6C4G]
P28335 5HT2C_HUMAN Alzheimer disease [ICD-11: 8A20]
P28335 5HT2C_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P28335 5HT2C_HUMAN Chronic insomnia [ICD-11: 7A00]
P28335 5HT2C_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P28335 5HT2C_HUMAN Parkinsonism [ICD-11: 8A00]
P28335 5HT2C_HUMAN Schizophrenia [ICD-11: 6A20]
P28335 5HT2C_HUMAN Sleep-wake disorder [ICD-11: 7A00-7B2Z]
P28335 5HT2C_HUMAN Tonus and reflex abnormality [ICD-11: MB47]
P28335 5HT2C_HUMAN Acute diabete complication [ICD-11: 5A2Y]
P28335 5HT2C_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P28335 5HT2C_HUMAN Substance abuse [ICD-11: 6C40]
P28335 5HT2C_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
P28335 5HT2C_HUMAN Mood disorder [ICD-11: 6A60-6E23]
P28335 5HT2C_HUMAN Dissociative neurological symptom disorder [ICD-11: 6B60]
P28335 5HT2C_HUMAN Depression [ICD-11: 6A70-6A7Z]
P28335 5HT2C_HUMAN Migraine [ICD-11: 8A80]
P28335 5HT2C_HUMAN Obesity [ICD-11: 5B80-5B81]
P28335 5HT2C_HUMAN Pain [ICD-11: MG30-MG3Z]
P28335 5HT2C_HUMAN Pituitary gland disorder [ICD-11: 5A60-5A61]
P28335 5HT2C_HUMAN Psychoactive substances use disorder [ICD-11: 6C4G]
P28335 5HT2C_HUMAN Alzheimer disease [ICD-11: 8A20]
P28335 5HT2C_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P28335 5HT2C_HUMAN Chronic insomnia [ICD-11: 7A00]
P28335 5HT2C_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P28335 5HT2C_HUMAN Parkinsonism [ICD-11: 8A00]
P28335 5HT2C_HUMAN Schizophrenia [ICD-11: 6A20]
P28335 5HT2C_HUMAN Sleep-wake disorder [ICD-11: 7A00-7B2Z]
P28335 5HT2C_HUMAN Tonus and reflex abnormality [ICD-11: MB47]
P28335 5HT2C_HUMAN Acute diabete complication [ICD-11: 5A2Y]
P28335 5HT2C_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P28335 5HT2C_HUMAN Substance abuse [ICD-11: 6C40]
P28335 5HT2C_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
P28335 5HT2C_HUMAN Mood disorder [ICD-11: 6A60-6E23]
P28335 5HT2C_HUMAN Dissociative neurological symptom disorder [ICD-11: 6B60]
P28335 5HT2C_HUMAN Depression [ICD-11: 6A70-6A7Z]
P28335 5HT2C_HUMAN Migraine [ICD-11: 8A80]
P28335 5HT2C_HUMAN Obesity [ICD-11: 5B80-5B81]
P28335 5HT2C_HUMAN Pain [ICD-11: MG30-MG3Z]
P28335 5HT2C_HUMAN Pituitary gland disorder [ICD-11: 5A60-5A61]
P28335 5HT2C_HUMAN Psychoactive substances use disorder [ICD-11: 6C4G]
P28335 5HT2C_HUMAN Alzheimer disease [ICD-11: 8A20]
P28335 5HT2C_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P28335 5HT2C_HUMAN Chronic insomnia [ICD-11: 7A00]
P28335 5HT2C_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P28335 5HT2C_HUMAN Parkinsonism [ICD-11: 8A00]
P28335 5HT2C_HUMAN Schizophrenia [ICD-11: 6A20]
P28335 5HT2C_HUMAN Sleep-wake disorder [ICD-11: 7A00-7B2Z]
P28335 5HT2C_HUMAN Tonus and reflex abnormality [ICD-11: MB47]
P28335 5HT2C_HUMAN Acute diabete complication [ICD-11: 5A2Y]
P28335 5HT2C_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P28335 5HT2C_HUMAN Substance abuse [ICD-11: 6C40]
P28335 5HT2C_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
P28335 5HT2C_HUMAN Mood disorder [ICD-11: 6A60-6E23]
P28335 5HT2C_HUMAN Dissociative neurological symptom disorder [ICD-11: 6B60]
P28335 5HT2C_HUMAN Depression [ICD-11: 6A70-6A7Z]
P28335 5HT2C_HUMAN Migraine [ICD-11: 8A80]
P28335 5HT2C_HUMAN Obesity [ICD-11: 5B80-5B81]
P28335 5HT2C_HUMAN Pain [ICD-11: MG30-MG3Z]
P28335 5HT2C_HUMAN Pituitary gland disorder [ICD-11: 5A60-5A61]
P28335 5HT2C_HUMAN Psychoactive substances use disorder [ICD-11: 6C4G]
P28335 5HT2C_HUMAN Alzheimer disease [ICD-11: 8A20]
P28335 5HT2C_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P28335 5HT2C_HUMAN Chronic insomnia [ICD-11: 7A00]
P28335 5HT2C_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P28335 5HT2C_HUMAN Parkinsonism [ICD-11: 8A00]
P28335 5HT2C_HUMAN Schizophrenia [ICD-11: 6A20]
P28335 5HT2C_HUMAN Sleep-wake disorder [ICD-11: 7A00-7B2Z]
P28335 5HT2C_HUMAN Tonus and reflex abnormality [ICD-11: MB47]
P28335 5HT2C_HUMAN Acute diabete complication [ICD-11: 5A2Y]
P28335 5HT2C_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P28335 5HT2C_HUMAN Substance abuse [ICD-11: 6C40]
P28335 5HT2C_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
P28335 5HT2C_HUMAN Mood disorder [ICD-11: 6A60-6E23]
P28335 5HT2C_HUMAN Dissociative neurological symptom disorder [ICD-11: 6B60]
P31645 SC6A4_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
P31645 SC6A4_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P31645 SC6A4_HUMAN Binge eating disorder [ICD-11: 6B82]
P31645 SC6A4_HUMAN Chronic pain [ICD-11: MG30]
P31645 SC6A4_HUMAN concerning food/fluid intake symptom [ICD-11: MG43]
P31645 SC6A4_HUMAN Corneal disease [ICD-11: 9A76-9A78]
P31645 SC6A4_HUMAN Cough [ICD-11: MD12]
P31645 SC6A4_HUMAN Depression [ICD-11: 6A70-6A7Z]
P31645 SC6A4_HUMAN Menopausal disorder [ICD-11: GA30]
P31645 SC6A4_HUMAN Migraine [ICD-11: 8A80]
P31645 SC6A4_HUMAN Mood disorder [ICD-11: 6A60-6E23]
P31645 SC6A4_HUMAN Nicotine use disorder [ICD-11: 6C4A]
P31645 SC6A4_HUMAN Obesity [ICD-11: 5B80-5B81]
P31645 SC6A4_HUMAN Pain [ICD-11: MG30-MG3Z]
P31645 SC6A4_HUMAN Alzheimer disease [ICD-11: 8A20]
P31645 SC6A4_HUMAN General pain disorder [ICD-11: 8E43]
P31645 SC6A4_HUMAN Insomnia [ICD-11: 7A00-7A0Z]
P31645 SC6A4_HUMAN Neurobehavioral disorder [ICD-11: 8A00-8A0Z]
P31645 SC6A4_HUMAN Schizophrenia [ICD-11: 6A20]
P31645 SC6A4_HUMAN Substance abuse [ICD-11: 6C40]
P31645 SC6A4_HUMAN Cocaine use disorder [ICD-11: 6C45]
P31645 SC6A4_HUMAN Ejaculatory dysfunction [ICD-11: HA03]
P31645 SC6A4_HUMAN Orthostatic hypotension [ICD-11: BA21]
P31645 SC6A4_HUMAN Parkinsonism [ICD-11: 8A00]
P31645 SC6A4_HUMAN Nausea/vomiting [ICD-11: MD90]
P31645 SC6A4_HUMAN Soft tissue disorder [ICD-11: FB56]
P31645 SC6A4_HUMAN Dissociative neurological symptom disorder [ICD-11: 6B60]
P31645 SC6A4_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
P31645 SC6A4_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P35367 HRH1_HUMAN Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z]
P35367 HRH1_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
P35367 HRH1_HUMAN Breathing abnormality [ICD-11: MD11]
P35367 HRH1_HUMAN Conjunctiva disorder [ICD-11: 9A60]
P35367 HRH1_HUMAN Corneal disease [ICD-11: 9A76-9A78]
P35367 HRH1_HUMAN Cough [ICD-11: MD12]
P35367 HRH1_HUMAN Depression [ICD-11: 6A70-6A7Z]
P35367 HRH1_HUMAN Episodic vestibular syndrome [ICD-11: AB31]
P35367 HRH1_HUMAN Headache [ICD-11: 8A80-8A84]
P35367 HRH1_HUMAN Insomnia [ICD-11: 7A00-7A0Z]
P35367 HRH1_HUMAN Morning sickness disorder [ICD-11: SC00]
P35367 HRH1_HUMAN Nasopharyngitis [ICD-11: CA00]
P35367 HRH1_HUMAN Nausea/vomiting [ICD-11: MD90]
P35367 HRH1_HUMAN Parkinsonism [ICD-11: 8A00]
P35367 HRH1_HUMAN Pruritus [ICD-11: EC90]
P35367 HRH1_HUMAN Respiratory system disease [ICD-11: CB40-CB7Z]
P35367 HRH1_HUMAN Rheumatoid arthritis [ICD-11: FA20]
P35367 HRH1_HUMAN Sleep-wake disorder [ICD-11: 7A00-7B2Z]
P35367 HRH1_HUMAN Vasomotor/allergic rhinitis [ICD-11: CA08]
P35367 HRH1_HUMAN Alzheimer disease [ICD-11: 8A20]
P35367 HRH1_HUMAN Asthma [ICD-11: CA23]
P35367 HRH1_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P35367 HRH1_HUMAN Bipolar disorder [ICD-11: 6A60]
P35367 HRH1_HUMAN Obesity [ICD-11: 5B80-5B81]
P35367 HRH1_HUMAN Schizophrenia [ICD-11: 6A20]
P35367 HRH1_HUMAN Pain [ICD-11: MG30-MG3Z]
P35462 DRD3_HUMAN Bipolar disorder [ICD-11: 6A60]
P35462 DRD3_HUMAN Parkinsonism [ICD-11: 8A00]
P35462 DRD3_HUMAN Schizophrenia [ICD-11: 6A20]
P35462 DRD3_HUMAN Alzheimer disease [ICD-11: 8A20]
P35462 DRD3_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P35462 DRD3_HUMAN Brain cancer [ICD-11: 2A00]
P35462 DRD3_HUMAN Depression [ICD-11: 6A70-6A7Z]
P35462 DRD3_HUMAN Endometrial cancer [ICD-11: 2C76]
P35462 DRD3_HUMAN Gastroduodenal motor/secretory disorder [ICD-11: DA41]
P35462 DRD3_HUMAN Leukaemia [ICD-11: 2A60-2B33]
P35462 DRD3_HUMAN Lymphoma [ICD-11: 2A80-2A86]
P35462 DRD3_HUMAN Multiple myeloma [ICD-11: 2A83]
P35462 DRD3_HUMAN Psychoactive substances use disorder [ICD-11: 6C4G]
P35462 DRD3_HUMAN Respiratory infection [ICD-11: CA07-CA4Z]
P35462 DRD3_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P35462 DRD3_HUMAN Stomach cancer [ICD-11: 2B72]
P35462 DRD3_HUMAN Nasopharyngeal cancer [ICD-11: 2B6B]
P35462 DRD3_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P35462 DRD3_HUMAN Orgasmic dysfunction [ICD-11: HA02]
P35462 DRD3_HUMAN Cocaine use disorder [ICD-11: 6C45]
P35462 DRD3_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P35462 DRD3_HUMAN Nausea/vomiting [ICD-11: MD90]
P35462 DRD3_HUMAN Nicotine use disorder [ICD-11: 6C4A]
P35462 DRD3_HUMAN Unspecific substance use disorder [ICD-11: 6C4Z]
P35462 DRD3_HUMAN Oesophagus motility disorder [ICD-11: DA21]
P35462 DRD3_HUMAN Bipolar disorder [ICD-11: 6A60]
P35462 DRD3_HUMAN Parkinsonism [ICD-11: 8A00]
P35462 DRD3_HUMAN Schizophrenia [ICD-11: 6A20]
P35462 DRD3_HUMAN Alzheimer disease [ICD-11: 8A20]
P35462 DRD3_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P35462 DRD3_HUMAN Brain cancer [ICD-11: 2A00]
P35462 DRD3_HUMAN Depression [ICD-11: 6A70-6A7Z]
P35462 DRD3_HUMAN Endometrial cancer [ICD-11: 2C76]
P35462 DRD3_HUMAN Gastroduodenal motor/secretory disorder [ICD-11: DA41]
P35462 DRD3_HUMAN Leukaemia [ICD-11: 2A60-2B33]
P35462 DRD3_HUMAN Lymphoma [ICD-11: 2A80-2A86]
P35462 DRD3_HUMAN Multiple myeloma [ICD-11: 2A83]
P35462 DRD3_HUMAN Psychoactive substances use disorder [ICD-11: 6C4G]
P35462 DRD3_HUMAN Respiratory infection [ICD-11: CA07-CA4Z]
P35462 DRD3_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P35462 DRD3_HUMAN Stomach cancer [ICD-11: 2B72]
P35462 DRD3_HUMAN Nasopharyngeal cancer [ICD-11: 2B6B]
P35462 DRD3_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P35462 DRD3_HUMAN Orgasmic dysfunction [ICD-11: HA02]
P35462 DRD3_HUMAN Cocaine use disorder [ICD-11: 6C45]
P35462 DRD3_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P35462 DRD3_HUMAN Nausea/vomiting [ICD-11: MD90]
P35462 DRD3_HUMAN Nicotine use disorder [ICD-11: 6C4A]
P35462 DRD3_HUMAN Unspecific substance use disorder [ICD-11: 6C4Z]
P35462 DRD3_HUMAN Oesophagus motility disorder [ICD-11: DA21]
P41595 5HT2B_HUMAN Depression [ICD-11: 6A70-6A7Z]
P41595 5HT2B_HUMAN Pituitary gland disorder [ICD-11: 5A60-5A61]
P41595 5HT2B_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P41595 5HT2B_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P41595 5HT2B_HUMAN Pulmonary hypertension [ICD-11: BB01]
P41595 5HT2B_HUMAN Coronary atherosclerosis [ICD-11: BA80]
P41595 5HT2B_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
P41595 5HT2B_HUMAN Migraine [ICD-11: 8A80]
P41595 5HT2B_HUMAN Irritable bowel syndrome [ICD-11: DD91]
P41595 5HT2B_HUMAN Depression [ICD-11: 6A70-6A7Z]
P41595 5HT2B_HUMAN Pituitary gland disorder [ICD-11: 5A60-5A61]
P41595 5HT2B_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P41595 5HT2B_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P41595 5HT2B_HUMAN Pulmonary hypertension [ICD-11: BB01]
P41595 5HT2B_HUMAN Coronary atherosclerosis [ICD-11: BA80]
P41595 5HT2B_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
P41595 5HT2B_HUMAN Migraine [ICD-11: 8A80]
P41595 5HT2B_HUMAN Irritable bowel syndrome [ICD-11: DD91]
P41595 5HT2B_HUMAN Depression [ICD-11: 6A70-6A7Z]
P41595 5HT2B_HUMAN Pituitary gland disorder [ICD-11: 5A60-5A61]
P41595 5HT2B_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P41595 5HT2B_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P41595 5HT2B_HUMAN Pulmonary hypertension [ICD-11: BB01]
P41595 5HT2B_HUMAN Coronary atherosclerosis [ICD-11: BA80]
P41595 5HT2B_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
P41595 5HT2B_HUMAN Migraine [ICD-11: 8A80]
P41595 5HT2B_HUMAN Irritable bowel syndrome [ICD-11: DD91]
P41595 5HT2B_HUMAN Depression [ICD-11: 6A70-6A7Z]
P41595 5HT2B_HUMAN Pituitary gland disorder [ICD-11: 5A60-5A61]
P41595 5HT2B_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P41595 5HT2B_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P41595 5HT2B_HUMAN Pulmonary hypertension [ICD-11: BB01]
P41595 5HT2B_HUMAN Coronary atherosclerosis [ICD-11: BA80]
P41595 5HT2B_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
P41595 5HT2B_HUMAN Migraine [ICD-11: 8A80]
P41595 5HT2B_HUMAN Irritable bowel syndrome [ICD-11: DD91]
P41595 5HT2B_HUMAN Depression [ICD-11: 6A70-6A7Z]
P41595 5HT2B_HUMAN Pituitary gland disorder [ICD-11: 5A60-5A61]
P41595 5HT2B_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P41595 5HT2B_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P41595 5HT2B_HUMAN Pulmonary hypertension [ICD-11: BB01]
P41595 5HT2B_HUMAN Coronary atherosclerosis [ICD-11: BA80]
P41595 5HT2B_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
P41595 5HT2B_HUMAN Migraine [ICD-11: 8A80]
P41595 5HT2B_HUMAN Irritable bowel syndrome [ICD-11: DD91]
P41595 5HT2B_HUMAN Depression [ICD-11: 6A70-6A7Z]
P41595 5HT2B_HUMAN Pituitary gland disorder [ICD-11: 5A60-5A61]
P41595 5HT2B_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P41595 5HT2B_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P41595 5HT2B_HUMAN Pulmonary hypertension [ICD-11: BB01]
P41595 5HT2B_HUMAN Coronary atherosclerosis [ICD-11: BA80]
P41595 5HT2B_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
P41595 5HT2B_HUMAN Migraine [ICD-11: 8A80]
P41595 5HT2B_HUMAN Irritable bowel syndrome [ICD-11: DD91]
P41595 5HT2B_HUMAN Depression [ICD-11: 6A70-6A7Z]
P41595 5HT2B_HUMAN Pituitary gland disorder [ICD-11: 5A60-5A61]
P41595 5HT2B_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P41595 5HT2B_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P41595 5HT2B_HUMAN Pulmonary hypertension [ICD-11: BB01]
P41595 5HT2B_HUMAN Coronary atherosclerosis [ICD-11: BA80]
P41595 5HT2B_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
P41595 5HT2B_HUMAN Migraine [ICD-11: 8A80]
P41595 5HT2B_HUMAN Irritable bowel syndrome [ICD-11: DD91]
P41595 5HT2B_HUMAN Depression [ICD-11: 6A70-6A7Z]
P41595 5HT2B_HUMAN Pituitary gland disorder [ICD-11: 5A60-5A61]
P41595 5HT2B_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P41595 5HT2B_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P41595 5HT2B_HUMAN Pulmonary hypertension [ICD-11: BB01]
P41595 5HT2B_HUMAN Coronary atherosclerosis [ICD-11: BA80]
P41595 5HT2B_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
P41595 5HT2B_HUMAN Migraine [ICD-11: 8A80]
P41595 5HT2B_HUMAN Irritable bowel syndrome [ICD-11: DD91]
P50406 5HT6R_HUMAN Alzheimer disease [ICD-11: 8A20]
P50406 5HT6R_HUMAN Schizophrenia [ICD-11: 6A20]
P50406 5HT6R_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
P50406 5HT6R_HUMAN Dissociative neurological symptom disorder [ICD-11: 6B60]
P50406 5HT6R_HUMAN Mild neurocognitive disorder [ICD-11: 6D71]
P50406 5HT6R_HUMAN Parkinsonism [ICD-11: 8A00]
P50406 5HT6R_HUMAN Neurodegenerative disorder [ICD-11: 8A20-8A23]
P50406 5HT6R_HUMAN Obesity [ICD-11: 5B80-5B81]
P50406 5HT6R_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P50406 5HT6R_HUMAN Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z]
P50406 5HT6R_HUMAN Nausea/vomiting [ICD-11: MD90]
Q96KQ7 EHMT2_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
Q96KQ7 EHMT2_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
Q96KQ7 EHMT2_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P11387 TOP1_HUMAN Bacterial infection [ICD-11: 1A00-1C4Z]
P11387 TOP1_HUMAN Colorectal cancer [ICD-11: 2B91]
P11387 TOP1_HUMAN Lung cancer [ICD-11: 2C25]
P11387 TOP1_HUMAN Ovarian cancer [ICD-11: 2C73]
P11387 TOP1_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P11387 TOP1_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P11387 TOP1_HUMAN Human immunodeficiency virus disease [ICD-11: 1C60-1C62]
P11387 TOP1_HUMAN Stomach cancer [ICD-11: 2B72]
P11387 TOP1_HUMAN Brain cancer [ICD-11: 2A00]
P11387 TOP1_HUMAN Esophageal cancer [ICD-11: 2B70]
P11387 TOP1_HUMAN Myelodysplastic syndrome [ICD-11: 2A37]
P11387 TOP1_HUMAN Renal cell carcinoma [ICD-11: 2C90]
P11387 TOP1_HUMAN Gastrointestinal stromal tumour [ICD-11: 2B5B]
P11387 TOP1_HUMAN Lymphoma [ICD-11: 2A80-2A86]
P11387 TOP1_HUMAN Mature B-cell lymphoma [ICD-11: 2A85]
P11387 TOP1_HUMAN Bladder cancer [ICD-11: 2C94]
P30304 MPIP1_HUMAN Asthma [ICD-11: CA23]
P30304 MPIP1_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P42345 MTOR_HUMAN Arteries/arterioles disorder [ICD-11: BD52]
P42345 MTOR_HUMAN Chronic myelomonocytic leukaemia [ICD-11: 2A40]
P42345 MTOR_HUMAN Hydrocephalus [ICD-11: 8D64]
P42345 MTOR_HUMAN Multiple myeloma [ICD-11: 2A83]
P42345 MTOR_HUMAN Renal cell carcinoma [ICD-11: 2C90]
P42345 MTOR_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P42345 MTOR_HUMAN Transplant rejection [ICD-11: NE84]
P42345 MTOR_HUMAN Sarcoma [ICD-11: 2A60-2C35]
P42345 MTOR_HUMAN Bladder cancer [ICD-11: 2C94]
P42345 MTOR_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P42345 MTOR_HUMAN Endometrial cancer [ICD-11: 2C76]
P42345 MTOR_HUMAN Head and neck cancer [ICD-11: 2D42]
P42345 MTOR_HUMAN Liver cancer [ICD-11: 2C12]
P42345 MTOR_HUMAN Lung cancer [ICD-11: 2C25]
P42345 MTOR_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P42345 MTOR_HUMAN Malignant mesenchymal neoplasm [ICD-11: 2B5D-2B5Y]
P42345 MTOR_HUMAN Metastatic lymph node neoplasm [ICD-11: 2D60]
P42345 MTOR_HUMAN Pain [ICD-11: MG30-MG3Z]
P42345 MTOR_HUMAN Pancreatic cancer [ICD-11: 2C10]
P42345 MTOR_HUMAN Prostate cancer [ICD-11: 2C82]
P42345 MTOR_HUMAN Pulmonary hypertension [ICD-11: BB01]
P42345 MTOR_HUMAN Lymphangioleiomyomatosis [ICD-11: CB07]
P42345 MTOR_HUMAN Lymphoma [ICD-11: 2A80-2A86]
P42345 MTOR_HUMAN Pleural mesothelioma [ICD-11: 2C26]
P42345 MTOR_HUMAN Mature T-cell lymphoma [ICD-11: 2A90]
P42345 MTOR_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
P42345 MTOR_HUMAN Ulcerative colitis [ICD-11: DD71]
P35348 ADA1A_HUMAN Hypertension [ICD-11: BA00-BA04]
P35348 ADA1A_HUMAN Prostate hyperplasia [ICD-11: GA90]
P35348 ADA1A_HUMAN Mild neurocognitive disorder [ICD-11: 6D71]
P35348 ADA1A_HUMAN Prostate cancer [ICD-11: 2C82]
P35348 ADA1A_HUMAN Pain [ICD-11: MG30-MG3Z]
P35348 ADA1A_HUMAN Abnormal micturition [ICD-11: MF50]
P35348 ADA1A_HUMAN Prostate disease [ICD-11: GA91]
P35348 ADA1A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P35348 ADA1A_HUMAN Post-traumatic stress disorder [ICD-11: 6B40]
P35348 ADA1A_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P35348 ADA1A_HUMAN Glaucoma [ICD-11: 9C61]
P35348 ADA1A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P35348 ADA1A_HUMAN Hypertension [ICD-11: BA00-BA04]
P35348 ADA1A_HUMAN Prostate hyperplasia [ICD-11: GA90]
P35348 ADA1A_HUMAN Mild neurocognitive disorder [ICD-11: 6D71]
P35348 ADA1A_HUMAN Prostate cancer [ICD-11: 2C82]
P35348 ADA1A_HUMAN Pain [ICD-11: MG30-MG3Z]
P35348 ADA1A_HUMAN Abnormal micturition [ICD-11: MF50]
P35348 ADA1A_HUMAN Prostate disease [ICD-11: GA91]
P35348 ADA1A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P35348 ADA1A_HUMAN Post-traumatic stress disorder [ICD-11: 6B40]
P35348 ADA1A_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P35348 ADA1A_HUMAN Glaucoma [ICD-11: 9C61]
P35348 ADA1A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P35348 ADA1A_HUMAN Hypertension [ICD-11: BA00-BA04]
P35348 ADA1A_HUMAN Prostate hyperplasia [ICD-11: GA90]
P35348 ADA1A_HUMAN Mild neurocognitive disorder [ICD-11: 6D71]
P35348 ADA1A_HUMAN Prostate cancer [ICD-11: 2C82]
P35348 ADA1A_HUMAN Pain [ICD-11: MG30-MG3Z]
P35348 ADA1A_HUMAN Abnormal micturition [ICD-11: MF50]
P35348 ADA1A_HUMAN Prostate disease [ICD-11: GA91]
P35348 ADA1A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P35348 ADA1A_HUMAN Post-traumatic stress disorder [ICD-11: 6B40]
P35348 ADA1A_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P35348 ADA1A_HUMAN Glaucoma [ICD-11: 9C61]
P35348 ADA1A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P35348 ADA1A_HUMAN Hypertension [ICD-11: BA00-BA04]
P35348 ADA1A_HUMAN Prostate hyperplasia [ICD-11: GA90]
P35348 ADA1A_HUMAN Mild neurocognitive disorder [ICD-11: 6D71]
P35348 ADA1A_HUMAN Prostate cancer [ICD-11: 2C82]
P35348 ADA1A_HUMAN Pain [ICD-11: MG30-MG3Z]
P35348 ADA1A_HUMAN Abnormal micturition [ICD-11: MF50]
P35348 ADA1A_HUMAN Prostate disease [ICD-11: GA91]
P35348 ADA1A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P35348 ADA1A_HUMAN Post-traumatic stress disorder [ICD-11: 6B40]
P35348 ADA1A_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P35348 ADA1A_HUMAN Glaucoma [ICD-11: 9C61]
P35348 ADA1A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P35348 ADA1A_HUMAN Hypertension [ICD-11: BA00-BA04]
P35348 ADA1A_HUMAN Prostate hyperplasia [ICD-11: GA90]
P35348 ADA1A_HUMAN Mild neurocognitive disorder [ICD-11: 6D71]
P35348 ADA1A_HUMAN Prostate cancer [ICD-11: 2C82]
P35348 ADA1A_HUMAN Pain [ICD-11: MG30-MG3Z]
P35348 ADA1A_HUMAN Abnormal micturition [ICD-11: MF50]
P35348 ADA1A_HUMAN Prostate disease [ICD-11: GA91]
P35348 ADA1A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P35348 ADA1A_HUMAN Post-traumatic stress disorder [ICD-11: 6B40]
P35348 ADA1A_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P35348 ADA1A_HUMAN Glaucoma [ICD-11: 9C61]
P35348 ADA1A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P35348 ADA1A_HUMAN Hypertension [ICD-11: BA00-BA04]
P35348 ADA1A_HUMAN Prostate hyperplasia [ICD-11: GA90]
P35348 ADA1A_HUMAN Mild neurocognitive disorder [ICD-11: 6D71]
P35348 ADA1A_HUMAN Prostate cancer [ICD-11: 2C82]
P35348 ADA1A_HUMAN Pain [ICD-11: MG30-MG3Z]
P35348 ADA1A_HUMAN Abnormal micturition [ICD-11: MF50]
P35348 ADA1A_HUMAN Prostate disease [ICD-11: GA91]
P35348 ADA1A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P35348 ADA1A_HUMAN Post-traumatic stress disorder [ICD-11: 6B40]
P35348 ADA1A_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P35348 ADA1A_HUMAN Glaucoma [ICD-11: 9C61]
P35348 ADA1A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P35368 ADA1B_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P35368 ADA1B_HUMAN Hypertension [ICD-11: BA00-BA04]
P35368 ADA1B_HUMAN Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z]
P35368 ADA1B_HUMAN Obesity [ICD-11: 5B80-5B81]
P35368 ADA1B_HUMAN Pain [ICD-11: MG30-MG3Z]
P35368 ADA1B_HUMAN Abnormal micturition [ICD-11: MF50]
P35368 ADA1B_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P35368 ADA1B_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P35368 ADA1B_HUMAN Hypertension [ICD-11: BA00-BA04]
P35368 ADA1B_HUMAN Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z]
P35368 ADA1B_HUMAN Obesity [ICD-11: 5B80-5B81]
P35368 ADA1B_HUMAN Pain [ICD-11: MG30-MG3Z]
P35368 ADA1B_HUMAN Abnormal micturition [ICD-11: MF50]
P35368 ADA1B_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P35368 ADA1B_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P35368 ADA1B_HUMAN Hypertension [ICD-11: BA00-BA04]
P35368 ADA1B_HUMAN Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z]
P35368 ADA1B_HUMAN Obesity [ICD-11: 5B80-5B81]
P35368 ADA1B_HUMAN Pain [ICD-11: MG30-MG3Z]
P35368 ADA1B_HUMAN Abnormal micturition [ICD-11: MF50]
P35368 ADA1B_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P35368 ADA1B_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P35368 ADA1B_HUMAN Hypertension [ICD-11: BA00-BA04]
P35368 ADA1B_HUMAN Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z]
P35368 ADA1B_HUMAN Obesity [ICD-11: 5B80-5B81]
P35368 ADA1B_HUMAN Pain [ICD-11: MG30-MG3Z]
P35368 ADA1B_HUMAN Abnormal micturition [ICD-11: MF50]
P35368 ADA1B_HUMAN Genetic cardiac arrhythmia [ICD-11: BC65]
P15289 ARSA_HUMAN Lysosomal disease [ICD-11: 5C56]
P08908 5HT1A_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
P08908 5HT1A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P08908 5HT1A_HUMAN Hypertension [ICD-11: BA00-BA04]
P08908 5HT1A_HUMAN Migraine [ICD-11: 8A80]
P08908 5HT1A_HUMAN Mood disorder [ICD-11: 6A60-6E23]
P08908 5HT1A_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
P08908 5HT1A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P08908 5HT1A_HUMAN Alzheimer disease [ICD-11: 8A20]
P08908 5HT1A_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P08908 5HT1A_HUMAN Juvenile idiopathic arthritis [ICD-11: FA24]
P08908 5HT1A_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P08908 5HT1A_HUMAN Muscular atrophy [ICD-11: 8B61]
P08908 5HT1A_HUMAN Parkinsonism [ICD-11: 8A00]
P08908 5HT1A_HUMAN Psoriasis [ICD-11: EA90]
P08908 5HT1A_HUMAN Schizophrenia [ICD-11: 6A20]
P08908 5HT1A_HUMAN Skin/mucosal anomaly [ICD-11: LD27]
P08908 5HT1A_HUMAN Tonus and reflex abnormality [ICD-11: MB47]
P08908 5HT1A_HUMAN Intellectual development disorder [ICD-11: LD90]
P08908 5HT1A_HUMAN Mild neurocognitive disorder [ICD-11: 6D71]
P08908 5HT1A_HUMAN Bipolar disorder [ICD-11: 6A60]
P08908 5HT1A_HUMAN Bulimia nervosa [ICD-11: 6B81]
P08908 5HT1A_HUMAN Coronary atherosclerosis [ICD-11: BA80]
P08908 5HT1A_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P08908 5HT1A_HUMAN Hypoactive sexual desire dysfunction [ICD-11: HA00]
P08908 5HT1A_HUMAN Insomnia [ICD-11: 7A00-7A0Z]
P08908 5HT1A_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P08908 5HT1A_HUMAN Social anxiety disorder [ICD-11: 6B04]
P08908 5HT1A_HUMAN Ejaculatory dysfunction [ICD-11: HA03]
P08908 5HT1A_HUMAN Prostate hyperplasia [ICD-11: GA90]
P08908 5HT1A_HUMAN Addictive disorder [ICD-11: 6C50-6C5Z]
P08908 5HT1A_HUMAN Abnormal micturition [ICD-11: MF50]
P08908 5HT1A_HUMAN Episode [ICD-11: N.A.]
P08908 5HT1A_HUMAN Dystonic disorder [ICD-11: 8A02]
P08908 5HT1A_HUMAN Post-traumatic stress disorder [ICD-11: 6B40]
P08908 5HT1A_HUMAN Binge eating disorder [ICD-11: 6B82]
P08908 5HT1A_HUMAN Pain [ICD-11: MG30-MG3Z]
P08908 5HT1A_HUMAN Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z]
P08908 5HT1A_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
P08908 5HT1A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P08908 5HT1A_HUMAN Hypertension [ICD-11: BA00-BA04]
P08908 5HT1A_HUMAN Migraine [ICD-11: 8A80]
P08908 5HT1A_HUMAN Mood disorder [ICD-11: 6A60-6E23]
P08908 5HT1A_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
P08908 5HT1A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P08908 5HT1A_HUMAN Alzheimer disease [ICD-11: 8A20]
P08908 5HT1A_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P08908 5HT1A_HUMAN Juvenile idiopathic arthritis [ICD-11: FA24]
P08908 5HT1A_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P08908 5HT1A_HUMAN Muscular atrophy [ICD-11: 8B61]
P08908 5HT1A_HUMAN Parkinsonism [ICD-11: 8A00]
P08908 5HT1A_HUMAN Psoriasis [ICD-11: EA90]
P08908 5HT1A_HUMAN Schizophrenia [ICD-11: 6A20]
P08908 5HT1A_HUMAN Skin/mucosal anomaly [ICD-11: LD27]
P08908 5HT1A_HUMAN Tonus and reflex abnormality [ICD-11: MB47]
P08908 5HT1A_HUMAN Intellectual development disorder [ICD-11: LD90]
P08908 5HT1A_HUMAN Mild neurocognitive disorder [ICD-11: 6D71]
P08908 5HT1A_HUMAN Bipolar disorder [ICD-11: 6A60]
P08908 5HT1A_HUMAN Bulimia nervosa [ICD-11: 6B81]
P08908 5HT1A_HUMAN Coronary atherosclerosis [ICD-11: BA80]
P08908 5HT1A_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P08908 5HT1A_HUMAN Hypoactive sexual desire dysfunction [ICD-11: HA00]
P08908 5HT1A_HUMAN Insomnia [ICD-11: 7A00-7A0Z]
P08908 5HT1A_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P08908 5HT1A_HUMAN Social anxiety disorder [ICD-11: 6B04]
P08908 5HT1A_HUMAN Ejaculatory dysfunction [ICD-11: HA03]
P08908 5HT1A_HUMAN Prostate hyperplasia [ICD-11: GA90]
P08908 5HT1A_HUMAN Addictive disorder [ICD-11: 6C50-6C5Z]
P08908 5HT1A_HUMAN Abnormal micturition [ICD-11: MF50]
P08908 5HT1A_HUMAN Episode [ICD-11: N.A.]
P08908 5HT1A_HUMAN Dystonic disorder [ICD-11: 8A02]
P08908 5HT1A_HUMAN Post-traumatic stress disorder [ICD-11: 6B40]
P08908 5HT1A_HUMAN Binge eating disorder [ICD-11: 6B82]
P08908 5HT1A_HUMAN Pain [ICD-11: MG30-MG3Z]
P08908 5HT1A_HUMAN Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z]
P08908 5HT1A_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
P08908 5HT1A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P08908 5HT1A_HUMAN Hypertension [ICD-11: BA00-BA04]
P08908 5HT1A_HUMAN Migraine [ICD-11: 8A80]
P08908 5HT1A_HUMAN Mood disorder [ICD-11: 6A60-6E23]
P08908 5HT1A_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
P08908 5HT1A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P08908 5HT1A_HUMAN Alzheimer disease [ICD-11: 8A20]
P08908 5HT1A_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P08908 5HT1A_HUMAN Juvenile idiopathic arthritis [ICD-11: FA24]
P08908 5HT1A_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P08908 5HT1A_HUMAN Muscular atrophy [ICD-11: 8B61]
P08908 5HT1A_HUMAN Parkinsonism [ICD-11: 8A00]
P08908 5HT1A_HUMAN Psoriasis [ICD-11: EA90]
P08908 5HT1A_HUMAN Schizophrenia [ICD-11: 6A20]
P08908 5HT1A_HUMAN Skin/mucosal anomaly [ICD-11: LD27]
P08908 5HT1A_HUMAN Tonus and reflex abnormality [ICD-11: MB47]
P08908 5HT1A_HUMAN Intellectual development disorder [ICD-11: LD90]
P08908 5HT1A_HUMAN Mild neurocognitive disorder [ICD-11: 6D71]
P08908 5HT1A_HUMAN Bipolar disorder [ICD-11: 6A60]
P08908 5HT1A_HUMAN Bulimia nervosa [ICD-11: 6B81]
P08908 5HT1A_HUMAN Coronary atherosclerosis [ICD-11: BA80]
P08908 5HT1A_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P08908 5HT1A_HUMAN Hypoactive sexual desire dysfunction [ICD-11: HA00]
P08908 5HT1A_HUMAN Insomnia [ICD-11: 7A00-7A0Z]
P08908 5HT1A_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P08908 5HT1A_HUMAN Social anxiety disorder [ICD-11: 6B04]
P08908 5HT1A_HUMAN Ejaculatory dysfunction [ICD-11: HA03]
P08908 5HT1A_HUMAN Prostate hyperplasia [ICD-11: GA90]
P08908 5HT1A_HUMAN Addictive disorder [ICD-11: 6C50-6C5Z]
P08908 5HT1A_HUMAN Abnormal micturition [ICD-11: MF50]
P08908 5HT1A_HUMAN Episode [ICD-11: N.A.]
P08908 5HT1A_HUMAN Dystonic disorder [ICD-11: 8A02]
P08908 5HT1A_HUMAN Post-traumatic stress disorder [ICD-11: 6B40]
P08908 5HT1A_HUMAN Binge eating disorder [ICD-11: 6B82]
P08908 5HT1A_HUMAN Pain [ICD-11: MG30-MG3Z]
P08908 5HT1A_HUMAN Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z]
P08908 5HT1A_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
P08908 5HT1A_HUMAN Depression [ICD-11: 6A70-6A7Z]
P08908 5HT1A_HUMAN Hypertension [ICD-11: BA00-BA04]
P08908 5HT1A_HUMAN Migraine [ICD-11: 8A80]
P08908 5HT1A_HUMAN Mood disorder [ICD-11: 6A60-6E23]
P08908 5HT1A_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
P08908 5HT1A_HUMAN Sexual dysfunction [ICD-11: HA00-HA01]
P08908 5HT1A_HUMAN Alzheimer disease [ICD-11: 8A20]
P08908 5HT1A_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P08908 5HT1A_HUMAN Juvenile idiopathic arthritis [ICD-11: FA24]
P08908 5HT1A_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P08908 5HT1A_HUMAN Muscular atrophy [ICD-11: 8B61]
P08908 5HT1A_HUMAN Parkinsonism [ICD-11: 8A00]
P08908 5HT1A_HUMAN Psoriasis [ICD-11: EA90]
P08908 5HT1A_HUMAN Schizophrenia [ICD-11: 6A20]
P08908 5HT1A_HUMAN Skin/mucosal anomaly [ICD-11: LD27]
P08908 5HT1A_HUMAN Tonus and reflex abnormality [ICD-11: MB47]
P08908 5HT1A_HUMAN Intellectual development disorder [ICD-11: LD90]
P08908 5HT1A_HUMAN Mild neurocognitive disorder [ICD-11: 6D71]
P08908 5HT1A_HUMAN Bipolar disorder [ICD-11: 6A60]
P08908 5HT1A_HUMAN Bulimia nervosa [ICD-11: 6B81]
P08908 5HT1A_HUMAN Coronary atherosclerosis [ICD-11: BA80]
P08908 5HT1A_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P08908 5HT1A_HUMAN Hypoactive sexual desire dysfunction [ICD-11: HA00]
P08908 5HT1A_HUMAN Insomnia [ICD-11: 7A00-7A0Z]
P08908 5HT1A_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P08908 5HT1A_HUMAN Social anxiety disorder [ICD-11: 6B04]
P08908 5HT1A_HUMAN Ejaculatory dysfunction [ICD-11: HA03]
P08908 5HT1A_HUMAN Prostate hyperplasia [ICD-11: GA90]
P08908 5HT1A_HUMAN Addictive disorder [ICD-11: 6C50-6C5Z]
P08908 5HT1A_HUMAN Abnormal micturition [ICD-11: MF50]
P08908 5HT1A_HUMAN Episode [ICD-11: N.A.]
P08908 5HT1A_HUMAN Dystonic disorder [ICD-11: 8A02]
P08908 5HT1A_HUMAN Post-traumatic stress disorder [ICD-11: 6B40]
P08908 5HT1A_HUMAN Binge eating disorder [ICD-11: 6B82]
P08908 5HT1A_HUMAN Pain [ICD-11: MG30-MG3Z]
P08908 5HT1A_HUMAN Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z]
P34972 CNR2_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P34972 CNR2_HUMAN Insomnia [ICD-11: 7A00-7A0Z]
P34972 CNR2_HUMAN Atopic eczema [ICD-11: EA80]
P34972 CNR2_HUMAN Crohn disease [ICD-11: DD70]
P34972 CNR2_HUMAN General pain disorder [ICD-11: 8E43]
P34972 CNR2_HUMAN Inborn lipid metabolism error [ICD-11: 5C52]
P34972 CNR2_HUMAN Pain [ICD-11: MG30-MG3Z]
P34972 CNR2_HUMAN Endometriosis [ICD-11: GA10]
P34972 CNR2_HUMAN Low bone mass disorder [ICD-11: FB83]
P34972 CNR2_HUMAN Prostate cancer [ICD-11: 2C82]
P34972 CNR2_HUMAN Transplant rejection [ICD-11: NE84]
P34972 CNR2_HUMAN Ischemia [ICD-11: 8B10-8B11]
P34972 CNR2_HUMAN Cerebral ischaemia [ICD-11: 8B1Z]
P34972 CNR2_HUMAN Rheumatoid arthritis [ICD-11: FA20]
P34972 CNR2_HUMAN Immune system disease [ICD-11: 4A01-4B41]
P34972 CNR2_HUMAN Indeterminate colitis [ICD-11: DD72]
P34972 CNR2_HUMAN Ovarian cancer [ICD-11: 2C73]
P34972 CNR2_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
P34969 5HT7R_HUMAN Alzheimer disease [ICD-11: 8A20]
P34969 5HT7R_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P34969 5HT7R_HUMAN Bipolar disorder [ICD-11: 6A60]
P34969 5HT7R_HUMAN Depression [ICD-11: 6A70-6A7Z]
P34969 5HT7R_HUMAN Mild neurocognitive disorder [ICD-11: 6D71]
P34969 5HT7R_HUMAN Parkinsonism [ICD-11: 8A00]
P34969 5HT7R_HUMAN Schizophrenia [ICD-11: 6A20]
P34969 5HT7R_HUMAN Sleep-wake disorder [ICD-11: 7A00-7B2Z]
P34969 5HT7R_HUMAN Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z]
P43119 PI2R_HUMAN Abortion [ICD-11: JA00]
P43119 PI2R_HUMAN Pulmonary hypertension [ICD-11: BB01]
P43119 PI2R_HUMAN Arterial occlusive disease [ICD-11: BD40]
P43119 PI2R_HUMAN Coronary atherosclerosis [ICD-11: BA80]
P43119 PI2R_HUMAN Gout [ICD-11: FA25]
P43119 PI2R_HUMAN Asthma [ICD-11: CA23]
P43119 PI2R_HUMAN Chronic kidney disease [ICD-11: GB61]
P43119 PI2R_HUMAN Hypertension [ICD-11: BA00-BA04]
P43119 PI2R_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
O43614 OX2R_HUMAN Insomnia [ICD-11: 7A00-7A0Z]
O43614 OX2R_HUMAN Depression [ICD-11: 6A70-6A7Z]
P21462 FPR1_HUMAN Peptic ulcer [ICD-11: DA61]
P21462 FPR1_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
P51685 CCR8_HUMAN Psoriasis [ICD-11: EA90]
P61073 CXCR4_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P61073 CXCR4_HUMAN Acute myeloid leukaemia [ICD-11: 2A60]
P61073 CXCR4_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
P61073 CXCR4_HUMAN Human immunodeficiency virus disease [ICD-11: 1C60-1C62]
P61073 CXCR4_HUMAN Innate/adaptive immunodeficiency [ICD-11: 4A00]
P61073 CXCR4_HUMAN Melanoma [ICD-11: 2C30]
P61073 CXCR4_HUMAN Multiple myeloma [ICD-11: 2A83]
P61073 CXCR4_HUMAN Myelodysplastic syndrome [ICD-11: 2A37]
P61073 CXCR4_HUMAN Neuroendocrine carcinoma [ICD-11: 2C34]
P61073 CXCR4_HUMAN Pancreatic cancer [ICD-11: 2C10]
P61073 CXCR4_HUMAN Renal cell carcinoma [ICD-11: 2C90]
P61073 CXCR4_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P61073 CXCR4_HUMAN Retinopathy [ICD-11: 9B71]
P61073 CXCR4_HUMAN Respiratory infection [ICD-11: CA07-CA4Z]
P61073 CXCR4_HUMAN Sarcoma [ICD-11: 2A60-2C35]
P61073 CXCR4_HUMAN Mature B-cell leukaemia [ICD-11: 2A82]
P61073 CXCR4_HUMAN Metastatic tumour [ICD-11: 2D50-2E2Z]
P61073 CXCR4_HUMAN Neutropenia [ICD-11: 4B00]
P61073 CXCR4_HUMAN Transplanted organ/tissue [ICD-11: QB63]
P61073 CXCR4_HUMAN Kaposi sarcoma [ICD-11: 2B57]
P61073 CXCR4_HUMAN Chronic arterial occlusive disease [ICD-11: BD4Z]
P61073 CXCR4_HUMAN Diabetes mellitus [ICD-11: 5A10]
P61073 CXCR4_HUMAN Mature B-cell lymphoma [ICD-11: 2A85]
P61073 CXCR4_HUMAN Psoriasis [ICD-11: EA90]
Q8TDV5 GP119_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
Q8TDV5 GP119_HUMAN Acute diabete complication [ICD-11: 5A2Y]
Q8TDV5 GP119_HUMAN Stomach cancer [ICD-11: 2B72]
Q8TDV5 GP119_HUMAN Type 2 diabetes mellitus [ICD-11: 5A11]
P28221 5HT1D_HUMAN Migraine [ICD-11: 8A80]
P28221 5HT1D_HUMAN Pituitary gland disorder [ICD-11: 5A60-5A61]
P28221 5HT1D_HUMAN Alzheimer disease [ICD-11: 8A20]
P28221 5HT1D_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P28221 5HT1D_HUMAN Epilepsy/seizure [ICD-11: 8A61-8A6Z]
P28221 5HT1D_HUMAN Insomnia [ICD-11: 7A00-7A0Z]
P28221 5HT1D_HUMAN Mood disorder [ICD-11: 6A60-6E23]
P28221 5HT1D_HUMAN Depression [ICD-11: 6A70-6A7Z]
P28221 5HT1D_HUMAN Migraine [ICD-11: 8A80]
P28221 5HT1D_HUMAN Pituitary gland disorder [ICD-11: 5A60-5A61]
P28221 5HT1D_HUMAN Alzheimer disease [ICD-11: 8A20]
P28221 5HT1D_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P28221 5HT1D_HUMAN Epilepsy/seizure [ICD-11: 8A61-8A6Z]
P28221 5HT1D_HUMAN Insomnia [ICD-11: 7A00-7A0Z]
P28221 5HT1D_HUMAN Mood disorder [ICD-11: 6A60-6E23]
P28221 5HT1D_HUMAN Depression [ICD-11: 6A70-6A7Z]
P28221 5HT1D_HUMAN Migraine [ICD-11: 8A80]
P28221 5HT1D_HUMAN Pituitary gland disorder [ICD-11: 5A60-5A61]
P28221 5HT1D_HUMAN Alzheimer disease [ICD-11: 8A20]
P28221 5HT1D_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P28221 5HT1D_HUMAN Epilepsy/seizure [ICD-11: 8A61-8A6Z]
P28221 5HT1D_HUMAN Insomnia [ICD-11: 7A00-7A0Z]
P28221 5HT1D_HUMAN Mood disorder [ICD-11: 6A60-6E23]
P28221 5HT1D_HUMAN Depression [ICD-11: 6A70-6A7Z]
P28221 5HT1D_HUMAN Migraine [ICD-11: 8A80]
P28221 5HT1D_HUMAN Pituitary gland disorder [ICD-11: 5A60-5A61]
P28221 5HT1D_HUMAN Alzheimer disease [ICD-11: 8A20]
P28221 5HT1D_HUMAN Dementia [ICD-11: 6D80-6D8Z]
P28221 5HT1D_HUMAN Epilepsy/seizure [ICD-11: 8A61-8A6Z]
P28221 5HT1D_HUMAN Insomnia [ICD-11: 7A00-7A0Z]
P28221 5HT1D_HUMAN Mood disorder [ICD-11: 6A60-6E23]
P28221 5HT1D_HUMAN Depression [ICD-11: 6A70-6A7Z]
P28222 5HT1B_HUMAN Migraine [ICD-11: 8A80]
P28222 5HT1B_HUMAN Pituitary gland disorder [ICD-11: 5A60-5A61]
P28222 5HT1B_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P28222 5HT1B_HUMAN Schizophrenia [ICD-11: 6A20]
P28222 5HT1B_HUMAN Alzheimer disease [ICD-11: 8A20]
P28222 5HT1B_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P28222 5HT1B_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P28222 5HT1B_HUMAN Parkinsonism [ICD-11: 8A00]
P28222 5HT1B_HUMAN Tonus and reflex abnormality [ICD-11: MB47]
P28222 5HT1B_HUMAN Mood disorder [ICD-11: 6A60-6E23]
P28222 5HT1B_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
P28222 5HT1B_HUMAN Depression [ICD-11: 6A70-6A7Z]
P28222 5HT1B_HUMAN Pain [ICD-11: MG30-MG3Z]
P28222 5HT1B_HUMAN Migraine [ICD-11: 8A80]
P28222 5HT1B_HUMAN Pituitary gland disorder [ICD-11: 5A60-5A61]
P28222 5HT1B_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P28222 5HT1B_HUMAN Schizophrenia [ICD-11: 6A20]
P28222 5HT1B_HUMAN Alzheimer disease [ICD-11: 8A20]
P28222 5HT1B_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P28222 5HT1B_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P28222 5HT1B_HUMAN Parkinsonism [ICD-11: 8A00]
P28222 5HT1B_HUMAN Tonus and reflex abnormality [ICD-11: MB47]
P28222 5HT1B_HUMAN Mood disorder [ICD-11: 6A60-6E23]
P28222 5HT1B_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
P28222 5HT1B_HUMAN Depression [ICD-11: 6A70-6A7Z]
P28222 5HT1B_HUMAN Pain [ICD-11: MG30-MG3Z]
P28222 5HT1B_HUMAN Migraine [ICD-11: 8A80]
P28222 5HT1B_HUMAN Pituitary gland disorder [ICD-11: 5A60-5A61]
P28222 5HT1B_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P28222 5HT1B_HUMAN Schizophrenia [ICD-11: 6A20]
P28222 5HT1B_HUMAN Alzheimer disease [ICD-11: 8A20]
P28222 5HT1B_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P28222 5HT1B_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P28222 5HT1B_HUMAN Parkinsonism [ICD-11: 8A00]
P28222 5HT1B_HUMAN Tonus and reflex abnormality [ICD-11: MB47]
P28222 5HT1B_HUMAN Mood disorder [ICD-11: 6A60-6E23]
P28222 5HT1B_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
P28222 5HT1B_HUMAN Depression [ICD-11: 6A70-6A7Z]
P28222 5HT1B_HUMAN Pain [ICD-11: MG30-MG3Z]
P28222 5HT1B_HUMAN Migraine [ICD-11: 8A80]
P28222 5HT1B_HUMAN Pituitary gland disorder [ICD-11: 5A60-5A61]
P28222 5HT1B_HUMAN Psychotic disorder [ICD-11: 6A20-6A25]
P28222 5HT1B_HUMAN Schizophrenia [ICD-11: 6A20]
P28222 5HT1B_HUMAN Alzheimer disease [ICD-11: 8A20]
P28222 5HT1B_HUMAN Attention deficit hyperactivity disorder [ICD-11: 6A05]
P28222 5HT1B_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P28222 5HT1B_HUMAN Parkinsonism [ICD-11: 8A00]
P28222 5HT1B_HUMAN Tonus and reflex abnormality [ICD-11: MB47]
P28222 5HT1B_HUMAN Mood disorder [ICD-11: 6A60-6E23]
P28222 5HT1B_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
P28222 5HT1B_HUMAN Depression [ICD-11: 6A70-6A7Z]
P28222 5HT1B_HUMAN Pain [ICD-11: MG30-MG3Z]
P28566 5HT1E_HUMAN Pituitary gland disorder [ICD-11: 5A60-5A61]
P28566 5HT1E_HUMAN Pituitary gland disorder [ICD-11: 5A60-5A61]
P30939 5HT1F_HUMAN Migraine [ICD-11: 8A80]
P30939 5HT1F_HUMAN Pituitary gland disorder [ICD-11: 5A60-5A61]
P30939 5HT1F_HUMAN Migraine [ICD-11: 8A80]
P30939 5HT1F_HUMAN Pituitary gland disorder [ICD-11: 5A60-5A61]